Query Psfainz_l4 Command /cluster/toolkit/production/bioprogs/hhpred/hhsearch -cal -cpu 4 -v 1 -i /cluster/toolkit/production/tmp/production/45244/1862708.hhm -d /cluster/toolkit/production/databases/hhpred/new_dbs/pdb70_28May07/db/pdb.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/scop70_1.72pre/db/scop.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/scop70_1.71/db/scop.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/pfamA_21.0/db/pfamA.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/smart_18Apr07/db/smart.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/panther_13Dec06/db/panther.hmm /cluster/toolkit/production/databases/hhpred/new_dbs/tigrfam_13Dec06/db/tigrfam.hmm /cluster/toolkit/production/databases/hhpred/new_dbs/pirsf_13Dec06/db/pirsf.hmm /cluster/toolkit/production/databases/hhpred/new_dbs/COG_18Apr07/db/COG.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/KOG_18Apr07/db/KOG.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/CATH_13Dec06/db/CATH.hmm /cluster/toolkit/production/databases/hhpred/new_dbs/supfam_13Dec06/db/supfam.hmm /cluster/toolkit/production/databases/hhpred/new_dbs/pfam_18Apr07/db//pfam.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/cd_18Apr07/db/cd.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/test56/db/test56.hhm /cluster/toolkit/production/databases/hhpred/new_dbs/test18/db/test18.hhm -o /cluster/toolkit/production/tmp/production/45244/1862708.hhr -p 20 -P 20 -Z 100 -B 100 -seq 1 -aliw 80 -local -ssm 2 -norealign -sc 1 No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM 1 d1ktdb2 d.19.1.1 (B:1-120) Cla 100.0 8.2E-43 0 252.2 5.4 81 2-84 34-115 (120) 2 d1i3rb2 d.19.1.1 (B:1-120) Cla 100.0 2.5E-42 0 249.6 6.0 81 2-84 33-114 (120) 3 d1uvqb2 d.19.1.1 (B:3-94) Clas 100.0 3.8E-42 0 248.6 6.0 81 2-84 5-86 (92) 4 d1uvqb2 d.19.1.1 (B:3-94) Clas 100.0 4.3E-42 0 248.3 6.0 81 2-84 5-86 (92) 5 d1fngb2 d.19.1.1 (B:4-92) Clas 100.0 8.1E-42 0 246.9 6.0 81 2-84 4-85 (89) 6 d1lnub2 d.19.1.1 (B:1-120) Cla 100.0 1.3E-41 0 245.8 6.2 81 2-84 33-114 (120) 7 d1fv1b2 d.19.1.1 (B:1-92) Clas 100.0 1.6E-41 0 245.3 6.2 81 2-84 7-88 (92) 8 d1fv1b2 d.19.1.1 (B:1-92) Clas 100.0 1.8E-41 0 245.0 6.2 81 2-84 7-88 (92) 9 d1lnub2 d.19.1.1 (B:1-120) Cla 100.0 2.1E-41 0 244.7 6.2 81 2-84 33-114 (120) 10 d1iakb2 d.19.1.1 (B:5-92) Clas 100.0 2E-39 2.1E-44 234.1 4.2 79 2-84 3-82 (87) 11 pfam00969 MHC_II_beta Class II 100.0 3.7E-38 3.9E-43 227.3 7.3 74 8-83 1-75 (75) 12 d1hdmb2 d.19.1.1 (B:3-87) Clas 100.0 8.7E-36 9.2E-41 214.6 5.4 80 2-84 1-81 (85) 13 PF00969 MHC_II_beta: Class II 100.0 9.9E-36 1.1E-40 214.3 5.7 74 8-83 1-75 (75) 14 1ktd_B Fusion protein consisti 100.0 8.7E-32 9.3E-37 193.2 5.4 81 2-84 34-115 (215) 15 d1k8ib2 d.19.1.1 (B:1-94) Clas 100.0 8.2E-32 8.7E-37 193.4 2.6 81 1-82 1-86 (94) 16 d1k8ib2 d.19.1.1 (B:1-94) Clas 100.0 2.4E-29 2.6E-34 180.2 2.6 81 1-82 1-86 (94) 17 1lnu_B H-2 class II histocompa 99.9 4.6E-28 4.9E-33 173.3 6.2 81 2-84 33-114 (217) 18 1ktdB01 3.10.320.10 99.9 4.8E-26 5.1E-31 162.5 7.5 82 1-84 33-115 (118) 19 1fne_B MHC class II I-EK, beta 99.9 2.1E-24 2.2E-29 153.8 6.0 81 2-84 33-114 (224) 20 d1hdmb2 d.19.1.1 (B:3-87) Clas 99.9 4.2E-23 4.4E-28 146.8 6.3 78 2-82 1-79 (85) 21 1a6aB01 3.10.320.10 99.9 1E-22 1.1E-27 144.8 7.0 82 1-84 2-84 (89) 22 2bc4_B HLA class II histocompa 99.8 2.9E-20 3.1E-25 131.6 5.5 81 1-82 2-87 (211) 23 1iao_B MHC class II I-AD; MHC 99.8 7.2E-19 7.7E-24 124.2 6.1 81 2-84 32-113 (222) 24 SUPFAM0021708 d.19.1 MHC antig 99.8 2.9E-18 3.1E-23 120.9 5.8 82 1-84 33-115 (120) 25 SUPFAM0022344 d.19.1 MHC antig 99.7 4.7E-18 5E-23 119.8 6.3 81 1-84 92-173 (181) 26 SUPFAM0024281 d.19.1 MHC antig 99.7 5.9E-18 6.3E-23 119.3 6.5 82 1-84 90-171 (179) 27 SUPFAM0020368 d.19.1 MHC antig 99.7 7E-18 7.4E-23 118.9 6.2 82 1-84 32-114 (120) 28 SUPFAM0018766 d.19.1 MHC antig 99.7 8.4E-18 9E-23 118.5 6.6 82 1-84 84-165 (173) 29 SUPFAM0021906 d.19.1 MHC antig 99.7 6.2E-18 6.6E-23 119.2 5.9 80 2-84 93-173 (181) 30 SUPFAM0016542 d.19.1 MHC antig 99.7 1.1E-17 1.2E-22 117.8 6.1 81 1-84 92-173 (181) 31 SUPFAM0023693 d.19.1 MHC antig 99.7 1.7E-17 1.8E-22 116.8 6.5 81 1-84 91-172 (180) 32 SUPFAM0016328 d.19.1 MHC antig 99.7 1.7E-17 1.8E-22 116.8 6.2 81 1-84 92-173 (181) 33 SUPFAM0022030 d.19.1 MHC antig 99.7 3.2E-17 3.4E-22 115.4 6.7 82 1-84 32-114 (120) 34 SUPFAM0019868 d.19.1 MHC antig 99.7 4.3E-17 4.6E-22 114.7 6.6 81 2-84 92-173 (181) 35 SUPFAM0020968 d.19.1 MHC antig 99.7 4.1E-17 4.3E-22 114.8 6.5 82 1-84 88-174 (181) 36 SUPFAM0019307 d.19.1 MHC antig 99.7 6E-17 6.4E-22 113.9 6.6 82 1-84 6-88 (92) 37 SUPFAM0018419 d.19.1 MHC antig 99.7 4.2E-17 4.5E-22 114.7 5.7 80 2-84 93-173 (181) 38 SUPFAM0017423 d.19.1 MHC antig 99.7 6.1E-17 6.5E-22 113.9 6.3 82 1-84 89-171 (179) 39 SUPFAM0021412 d.19.1 MHC antig 99.7 5.2E-17 5.6E-22 114.2 5.9 80 2-84 93-173 (181) 40 1uvq_B HLA class II histocompa 99.7 7.7E-17 8.2E-22 113.3 6.8 79 2-82 5-84 (198) 41 SUPFAM0017254 d.19.1 MHC antig 99.7 7.3E-17 7.8E-22 113.4 6.6 82 1-84 4-86 (90) 42 SUPFAM0022711 d.19.1 MHC antig 99.7 6.3E-17 6.7E-22 113.8 6.1 78 2-82 93-171 (181) 43 SUPFAM0017778 d.19.1 MHC antig 99.7 7.9E-17 8.4E-22 113.3 6.5 82 1-84 5-87 (91) 44 SUPFAM0022346 d.19.1 MHC antig 99.7 6E-17 6.4E-22 113.9 5.8 80 2-84 92-172 (180) 45 SUPFAM0021478 d.19.1 MHC antig 99.7 7.4E-17 7.9E-22 113.4 6.2 79 2-82 91-169 (178) 46 SUPFAM0018220 d.19.1 MHC antig 99.7 6.7E-17 7.2E-22 113.6 5.9 80 2-84 93-173 (181) 47 SUPFAM0016399 d.19.1 MHC antig 99.7 1.1E-16 1.2E-21 112.5 6.7 82 1-84 2-84 (88) 48 SUPFAM0018120 d.19.1 MHC antig 99.7 8.6E-17 9.1E-22 113.1 5.8 78 2-82 93-171 (181) 49 SUPFAM0021063 d.19.1 MHC antig 99.7 1.7E-16 1.8E-21 111.5 6.6 82 1-84 4-86 (92) 50 SUPFAM0016670 d.19.1 MHC antig 99.7 2.2E-16 2.4E-21 110.8 6.8 82 1-84 3-85 (89) 51 SUPFAM0021571 d.19.1 MHC antig 99.7 1.7E-16 1.9E-21 111.4 5.9 78 2-82 93-171 (181) 52 SUPFAM0020991 d.19.1 MHC antig 99.7 2.2E-16 2.3E-21 110.9 6.1 80 2-84 90-169 (174) 53 SUPFAM0024494 d.19.1 MHC antig 99.7 2.9E-16 3.1E-21 110.2 6.4 82 1-84 2-84 (89) 54 SUPFAM0020165 d.19.1 MHC antig 99.7 4.1E-16 4.4E-21 109.4 6.8 81 1-84 92-176 (181) 55 SUPFAM0020207 d.19.1 MHC antig 99.7 3.3E-16 3.5E-21 109.9 6.0 78 2-82 93-171 (181) 56 SUPFAM0016837 d.19.1 MHC antig 99.7 5E-16 5.4E-21 109.0 6.3 79 2-82 88-171 (180) 57 1es0_B 65 KD glutamic acid dec 99.6 6.4E-16 6.9E-21 108.4 6.5 79 2-84 33-112 (221) 58 SUPFAM0024649 d.19.1 MHC antig 99.6 5.1E-16 5.5E-21 108.9 5.9 78 2-82 93-171 (181) 59 SUPFAM0017878 d.19.1 MHC antig 99.6 6.4E-16 6.8E-21 108.4 6.3 79 2-82 91-169 (178) 60 SUPFAM0022064 d.19.1 MHC antig 99.6 9.8E-16 1E-20 107.4 6.9 76 2-79 87-167 (172) 61 PTHR19944 MHC CLASS II-RELATED 99.6 9.1E-20 9.7E-25 129.0 -14.5 78 2-81 44-138 (284) 62 SUPFAM0021328 d.19.1 MHC antig 99.6 5.9E-16 6.3E-21 108.6 4.9 80 1-84 2-82 (87) 63 SUPFAM0020064 d.19.1 MHC antig 99.6 3E-15 3.2E-20 104.8 6.6 80 2-84 1-81 (85) 64 SUPFAM0018655 d.19.1 MHC antig 99.6 3.2E-15 3.4E-20 104.7 6.0 80 1-84 2-82 (87) 65 SUPFAM0020208 d.19.1 MHC antig 99.6 5.1E-15 5.5E-20 103.6 6.7 76 2-80 93-175 (181) 66 SUPFAM0020450 d.19.1 MHC antig 99.6 6.2E-15 6.7E-20 103.1 5.9 80 1-84 2-82 (87) 67 SUPFAM0024675 d.19.1 MHC antig 99.5 3.4E-14 3.7E-19 99.1 6.3 76 2-79 90-165 (178) 68 SUPFAM0017311 d.19.1 MHC antig 99.3 5.8E-12 6.2E-17 87.2 6.8 72 2-81 90-162 (164) 69 SUPFAM0023656 d.19.1 MHC antig 99.1 4.2E-10 4.5E-15 77.3 6.0 75 2-79 92-167 (180) 70 SUPFAM0018479 d.19.1 MHC antig 99.0 1.8E-09 2E-14 73.9 6.7 72 2-76 93-165 (181) 71 3fru_A Neonatal FC receptor; H 98.8 3.3E-08 3.6E-13 67.1 7.4 75 2-78 90-164 (269) 72 1s7q_A H-2KB, H-2 class I hist 98.7 1.9E-07 2.1E-12 63.1 6.8 73 1-76 91-165 (348) 73 1exu_A IGG receptor FCRN large 98.5 3.6E-07 3.8E-12 61.6 5.8 77 4-82 90-166 (267) 74 1mhc_A MHC class I antigen H2- 98.5 5.3E-07 5.7E-12 60.7 5.9 71 2-75 93-164 (282) 75 1t7v_A Zinc-alpha-2-glycoprote 98.5 9.7E-07 1E-11 59.3 6.7 75 2-78 95-169 (278) 76 1k5n_A Major histocompatibilit 98.3 6.3E-06 6.7E-11 55.0 6.9 71 2-75 93-164 (276) 77 1a6z_A HFE; 2.6A {Homo sapiens 98.3 1.2E-05 1.3E-10 53.5 8.2 72 2-75 94-165 (275) 78 1zs8_A Histocompatibility 2, M 98.1 1.2E-05 1.3E-10 53.5 5.0 69 4-75 94-163 (274) 79 d1a6za2 d.19.1.1 (A:4-181) Hem 96.9 0.017 1.8E-07 36.7 8.2 72 2-75 91-162 (178) 80 1onq_A T-cell surface glycopro 96.6 0.016 1.8E-07 36.7 6.0 72 2-75 94-166 (283) 81 SUPFAM0017311 d.19.1 MHC antig 96.6 0.035 3.8E-07 34.9 7.6 69 1-69 1-69 (164) 82 d1t7va2 d.19.1.1 (A:5-183) Zin 96.5 0.044 4.7E-07 34.4 7.6 72 2-75 91-162 (179) 83 d3frua2 d.19.1.1 (A:1-178) Fc 96.4 0.076 8.1E-07 33.2 8.3 72 2-75 90-161 (178) 84 d1t7va2 d.19.1.1 (A:5-183) Zin 96.3 0.063 6.7E-07 33.6 7.6 72 2-75 91-162 (179) 85 1je6_A MICB, MHC class I chain 96.3 0.021 2.2E-07 36.1 5.0 72 2-75 89-165 (275) 86 d1de4a2 d.19.1.1 (A:4-181) Hem 96.1 0.059 6.3E-07 33.7 6.7 70 4-75 93-162 (178) 87 d3frua2 d.19.1.1 (A:1-178) Fc 96.1 0.14 1.5E-06 31.8 8.3 72 2-75 90-161 (178) 88 d1kcgc_ d.19.1.1 (C:) Class I 96.0 0.066 7.1E-07 33.5 6.6 70 4-75 93-162 (178) 89 d1kjva2 d.19.1.1 (A:1-181) Cla 96.0 0.076 8.1E-07 33.1 6.8 71 2-75 93-164 (181) 90 d1exua2 d.19.1.1 (A:4-176) Fc 96.0 0.11 1.2E-06 32.2 7.6 72 2-75 85-156 (173) 91 d1exua2 d.19.1.1 (A:4-176) Fc 95.8 0.13 1.4E-06 31.9 7.4 70 4-75 87-156 (173) 92 1zt4_A T-cell surface glycopro 95.7 0.14 1.5E-06 31.7 7.3 73 1-75 93-166 (281) 93 1cd1_A CD1, MCD1D.1; 2.67A {Mu 95.7 0.18 1.9E-06 31.2 7.7 72 2-75 93-165 (315) 94 d1k5na2 d.19.1.1 (A:1-181) Cla 95.7 0.12 1.3E-06 32.1 6.7 69 4-75 95-164 (181) 95 1kcg_C ULBP3 protein; protein- 95.5 0.16 1.7E-06 31.5 6.8 72 2-75 91-162 (178) 96 d1neza2 d.19.1.1 (A:1-181) Cla 95.4 0.16 1.7E-06 31.4 6.6 68 4-75 95-164 (181) 97 SUPFAM0021061 d.19.1 MHC antig 95.4 0.049 5.2E-07 34.2 3.8 54 21-81 19-72 (84) 98 d1kcgc_ d.19.1.1 (C:) Class I 95.4 0.19 2E-06 31.1 6.8 72 2-75 91-162 (178) 99 d1kjva2 d.19.1.1 (A:1-181) Cla 95.1 0.25 2.6E-06 30.4 6.8 70 2-75 93-164 (181) 100 d1neza2 d.19.1.1 (A:1-181) Cla 95.0 0.24 2.6E-06 30.5 6.6 68 4-75 95-164 (181) No 1 >d1ktdb2 d.19.1.1 (B:1-120) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-EK} Probab=100.00 E-value=8.2e-43 Score=252.17 Aligned_columns=81 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.++|||| |||| +||||.||||||+|++|||||||+|||+||||+|+||+|||||++||++||+|||||||||+ T Consensus 34 Fl~~~k~eC~f~NGTe--rVrfi~RyiyNreE~~rFdSdVG~fvg~TElG~~~Ae~wNsq~e~Le~~RA~vDt~CRhNy~ 111 (120) T d1ktdb2 34 FLEYCKSECHFYNGTQ--RVRLLVRYFYNLEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYE 111 (120) T ss_dssp EEEEEEEEEEESSGGG--SEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHHCHHHHHHHHHHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCCCHHHHCCCHHHHHHHHHCCCCCEECCCE T ss_conf 0467633678517951--46765534446834566708756162225555706456078867998861001330003421 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |+.| T Consensus 112 i~es 115 (120) T d1ktdb2 112 IFDN 115 (120) T ss_dssp HHTT T ss_pred EECC T ss_conf 1055 No 2 >d1i3rb2 d.19.1.1 (B:1-120) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-EK} SCOP: d1kt2b2 Probab=100.00 E-value=2.5e-42 Score=249.63 Aligned_columns=81 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.++||+| |||| +||||.||||||+|++|||||||+|||+||||+|+||+|||||++||++||+|||||||||+ T Consensus 33 Fl~q~k~eC~f~NGTe--rVrfi~RyiYNree~~rFdSdvG~fvg~TelG~~~Ae~wNsqke~Le~~Ra~VDt~CRhNY~ 110 (120) T d1i3rb2 33 FLEYCKSECHFYNGTQ--RVRLLVRYFYNLEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYE 110 (120) T ss_dssp EEEEEEEEEEEETGGG--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCE T ss_conf 0467633678517961--47776534446834566718756173125545706457078867998861001331003422 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |+.| T Consensus 111 i~es 114 (120) T d1i3rb2 111 IFDN 114 (120) T ss_dssp HHTT T ss_pred EECC T ss_conf 1055 No 3 >d1uvqb2 d.19.1.1 (B:3-94) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DQ6} Probab=100.00 E-value=3.8e-42 Score=248.60 Aligned_columns=81 Identities=27% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.|+||+| |||| +||||.||||||+|++|||||||+|||+||||+|+||+|||||++||++||+|||||||||| T Consensus 5 f~~~~k~eC~f~Ngte--rVr~l~r~iyNree~~rFdSdvG~fva~TelG~~~Ae~wNs~~e~Le~~Ra~vdt~CrhNy~ 82 (92) T d1uvqb2 5 FVFQFKGMCYFTNGTE--RVRLVTRYIYNREEYARFDSDVGVYRAVTPQGRPDAEYWNSQKEVLEGTRAELDTVCRHNYE 82 (92) T ss_dssp CEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred HHHHHHEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCCCHHHCCCCHHHHHHHHHHHHCCCCCCCC T ss_conf 5211010144207951--47887756667856788818877074112425601255079967988763221010024410 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |++| T Consensus 83 v~~~ 86 (92) T d1uvqb2 83 VAFR 86 (92) T ss_dssp HTHH T ss_pred CCCC T ss_conf 0124 No 4 >d1uvqb2 d.19.1.1 (B:3-94) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DQ6} SCOP: d1jk8b2 d1s9vb2 d1iaob2 d2iadb2 d1mujb2 d1iakb2 d1d9kd2 d1es0b2 d1f3jb2 d1k2db2 d1fngb2 d1r5vb2 Probab=100.00 E-value=4.3e-42 Score=248.35 Aligned_columns=81 Identities=27% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.|+||+| |||| +||||+|+||||+|++|||||||+|||+||+|+|+||+|||||++||++||+|||||||||| T Consensus 5 f~~~~k~eC~f~Ngte--rVrfl~r~iyNree~~rFdSdvG~fv~~TelG~~~Ae~wNs~~e~Le~~Ra~vdt~CrhNy~ 82 (92) T d1uvqb2 5 FVFQFKGMCYFTNGTE--RVRLVTRYIYNREEYARFDSDVGVYRAVTPQGRPDAEYWNSQKEVLEGTRAELDTVCRHNYE 82 (92) T ss_dssp CEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred HHEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEEEECCCCCCCHHHCCCCHHHHHHHHHHHHCCCCCCCC T ss_conf 5120101255307951--37887756557767788818777074003325601255079967988762221010124410 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |++| T Consensus 83 v~~~ 86 (92) T d1uvqb2 83 VAFR 86 (92) T ss_dssp HTHH T ss_pred CCCC T ss_conf 0124 No 5 >d1fngb2 d.19.1.1 (B:4-92) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-EK} Probab=100.00 E-value=8.1e-42 Score=246.87 Aligned_columns=81 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.++||+| |||+ +||||.||||||+|++|||||||||||+||||+|+||+|||||++||++||+|||||||||| T Consensus 4 F~e~~k~eC~f~ngte--rVr~i~r~iyN~ee~~rFdSdvG~fvg~TelG~~~Ae~wNs~~~~Le~~Ra~vdt~CrhNy~ 81 (89) T d1fngb2 4 FLEYCKSECHFYNGTQ--RVRLLVRYFYNLEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYE 81 (89) T ss_dssp EEEEEEEEEEESSGGG--SEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEEEECCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCE T ss_conf 7777635788617974--27888766656845677808766174005645716235278867988762100331004531 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |+.| T Consensus 82 i~es 85 (89) T d1fngb2 82 IFDN 85 (89) T ss_dssp HHTT T ss_pred EECC T ss_conf 1043 No 6 >d1lnub2 d.19.1.1 (B:1-120) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-AB} Probab=100.00 E-value=1.3e-41 Score=245.81 Aligned_columns=81 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.++|||| |||| +||||.||||||+|++|||||||+|||+||||+|+||+|||||++||++||+|||||||||+ T Consensus 33 F~~q~k~eC~f~NGTe--rVrfi~RyiYNreE~~rFdSdVGkfVg~TelG~~~Ae~wNsq~e~Le~~Ra~VDt~CRhNY~ 110 (120) T d1lnub2 33 FVYQFMGECYFTNGTQ--RIRYVTRYIYNREEYVRYDSDVGEHRAVTELGRPDAEYWNSQPEILERTRAELDTVCRHNYE 110 (120) T ss_dssp CEEEEEEEEECCTTTT--SCEEEEEEEETTEEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHTTHHHHTTHHHHH T ss_pred HEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCCCHHHHCCCHHHHHHHHHHCCCEEECCCC T ss_conf 4145444467517951--47876645447835677828767264445535603255078877998761000230212453 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..| T Consensus 111 ~~e~ 114 (120) T d1lnub2 111 GPET 114 (120) T ss_dssp TTTT T ss_pred CCCC T ss_conf 3454 No 7 >d1fv1b2 d.19.1.1 (B:1-92) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DR2} Probab=100.00 E-value=1.6e-41 Score=245.31 Aligned_columns=81 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.++|||| |||| +||||.||||||+|++|||||||||||+||||+|+||+|||||++||++||+|||||||||| T Consensus 7 fl~~~k~eC~f~ngte--~Vr~i~r~iyNr~e~~rFdSdvGkfva~TelG~~~Ae~wNs~~e~Le~~Ra~vd~~CrhNy~ 84 (92) T d1fv1b2 7 FLQQDKYECHFFNGTE--RVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEYWNSQKDFLEDRRAAVDTYCRHNYG 84 (92) T ss_dssp EEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHSHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEEEECCCCCCCHHHCCCCHHHHHHHHCCCCCCEECCEE T ss_conf 0467656688646963--26887756557846677808776173104335716246078867988750012450105424 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |..| T Consensus 85 i~e~ 88 (92) T d1fv1b2 85 VGES 88 (92) T ss_dssp HHGG T ss_pred EECC T ss_conf 2041 No 8 >d1fv1b2 d.19.1.1 (B:1-92) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DR2} SCOP: u1zgle2 d1klub2 d1hxyb2 d1aqdb2 d1d5zb2 d1d5mb2 d1j8hb2 d1bx2b2 d1a6ab2 Probab=100.00 E-value=1.8e-41 Score=245.05 Aligned_columns=81 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.+.+|+| |||| +||||.||||||+|++|||||||||||+||||+|+||+||+||++||++||+|||||||||| T Consensus 7 fl~~~k~eC~f~Ngte--~Vr~i~r~iyN~ee~~rFdSdvG~fvg~TelG~~~Ae~wNs~~e~Le~~Ra~vd~~CrhNy~ 84 (92) T d1fv1b2 7 FLQQDKYECHFFNGTE--RVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEYWNSQKDFLEDRRAAVDTYCRHNYG 84 (92) T ss_dssp EEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHSHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEEECCCCCCCHHHCCCCHHHHHHHHCCCCCCEECCEE T ss_conf 0467656688636963--26787656547845677808776174104325715145078867988750012450104424 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |..| T Consensus 85 i~e~ 88 (92) T d1fv1b2 85 VGES 88 (92) T ss_dssp HHGG T ss_pred EECC T ss_conf 2041 No 9 >d1lnub2 d.19.1.1 (B:1-120) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-AB} Probab=100.00 E-value=2.1e-41 Score=244.67 Aligned_columns=81 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.++|||| |||| +||||.||||||+|++|||||||+|||+||||+|+||+|||||++||++||+|||||||||+ T Consensus 33 F~~q~k~EC~f~NGTe--rVrfi~RyiYNree~~rFdSdVGkfVg~TelG~~~Ae~wNs~~e~Le~~Ra~VDt~CRhNY~ 110 (120) T d1lnub2 33 FVYQFMGECYFTNGTQ--RIRYVTRYIYNREEYVRYDSDVGEHRAVTELGRPDAEYWNSQPEILERTRAELDTVCRHNYE 110 (120) T ss_dssp CEEEEEEEEECCTTTT--SCEEEEEEEETTEEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHTTHHHHTTHHHHH T ss_pred HEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCCCHHHHCCCHHHHHHHHHCCCCEEECCCC T ss_conf 5045434467527940--57886645557835677828767163234435703256078878998761000230212453 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..| T Consensus 111 ~~e~ 114 (120) T d1lnub2 111 GPET 114 (120) T ss_dssp TTTT T ss_pred CCCC T ss_conf 3454 No 10 >d1iakb2 d.19.1.1 (B:5-92) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), I-AK} Probab=100.00 E-value=2e-39 Score=234.12 Aligned_columns=79 Identities=34% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.|++|+| |||| +||||.||||||+|++|||||||||||+||||+|+||+|||| +||++||+|||||||||+ T Consensus 3 F~~q~k~eC~f~NgTe--rVr~l~ryiyNk~e~~rFdSdvG~fvg~TelG~~~Ae~wN~~--~Le~~Ra~vdt~CrhNy~ 78 (87) T d1iakb2 3 FVHQFQPFCYFTNGTQ--RIRLVIRYIYNREEYVRFDSDVGEYRAVTELGRPDAEYWNKQ--YLERTRAELDTVCRHNYE 78 (87) T ss_dssp EEEEEEEEEEEETGGG--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHHH--THHHHHTHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEECCCCCEEECCCCCCCHHHHHCCHH--HHHHHCCCCCCEEEECCE T ss_conf 3576656777507851--478876455568345778176571741036788425552758--888650010230220220 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) |..| T Consensus 79 i~e~ 82 (87) T d1iakb2 79 KTET 82 (87) T ss_dssp HTTT T ss_pred EEEC T ss_conf 1201 No 11 >pfam00969 MHC_II_beta Class II histocompatibility antigen, beta domain. Probab=100.00 E-value=3.7e-38 Score=227.31 Aligned_columns=74 Identities=38% Q ss_pred EEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCCCC Q ss_conf 78886-57996205899888757699999807777487017301403245068866977675420340037764125 Q Psfainz_l4 8 DRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGIWY 83 (84) Q Consensus 8 ~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv~y 83 (84) ++|+| |||+ +||||.||||||+|++|||||||+|||+||||+|+||.|||||++||++||+||||||||||||+ T Consensus 1 ~eC~f~ngt~--~vr~i~r~iyN~~e~~~FdSdvG~fvg~TelG~~~Ae~wNs~~~~Le~~ra~vdt~CrhNy~v~~ 75 (75) T pfam00969 1 SECYFTNGTE--RVRFLDRYIYNREEYVRFDSDVGEFVAVTELGRPDAEYWNSQKDLLEQKRAEVDTYCRHNYGVWE 75 (75) T ss_pred CCEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEEECCCCCHHHHHHCCCHHHHHHHHHHHCCCCCCCCCCCC T ss_conf 9124408855--06887656657766787736886487105225123665088966988775320340116634579 No 12 >d1hdmb2 d.19.1.1 (B:3-87) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DM} Probab=100.00 E-value=8.7e-36 Score=214.63 Aligned_columns=80 Identities=13% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.+++|+| |||+ +|+|+.|++|||+|++|||||||||||+||+|+|+||+||+||++||+ |++||++||||++ T Consensus 1 F~~~~~~~C~f~n~~~--~~~f~~~~~yNk~e~~~fdSdvg~fv~~Te~G~~~Ae~~N~~~~~l~~-~~~vd~~CrhN~~ 77 (85) T d1hdmb2 1 FVAHVESTCLLDDAGT--PKDFTYCISFNKDLLTCWDPEENKMAPCNSLANVLSQHLNQKDTLMQR-LNGLQNCATHTQP 77 (85) T ss_dssp CEEEEEEEEEEETTSC--EEEEEEEEEETTEEEEEEETTTTEEEECCHHHHHHHHHHHTCHHHHHH-CCHHHHHHHHHTT T ss_pred CEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCCEEEECCHHHHHHHHHCCCCHHHHHH-HHHHHHHHHCCCC T ss_conf 9047677887648996--158999986667577888698876870272211586760899889999-9874325332565 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +|.| T Consensus 78 ~~~~ 81 (85) T d1hdmb2 78 FWGS 81 (85) T ss_dssp THHH T ss_pred CCCC T ss_conf 3210 No 13 >PF00969 MHC_II_beta: Class II histocompatibility antigen, beta domain; InterPro: IPR000353 Major Histocompatibility Complex (MHC) glycoproteins are heterodimeric cell surface receptors that function to present antigen peptide fragments to T cells responsible for cell-mediated immune responses. MHC molecules can be subdivided into two groups on the basis of structure and function: class I molecules present intracellular antigen peptide fragments (~10 amino acids) on the surface of the host cells to cytotoxic T cells; class II molecules present exogenously derived antigenic peptides (~15 amino acids) to helper T cells. MHC class I and II molecules are assembled and loaded with their peptide ligands via different mechanisms. However, both present peptide fragments rather than entire proteins to T cells, and are required to mount an immune response. Class II MHC glycoproteins are expressed on the surface of antigen-presenting cells (APC), including macrophages, dendritic cells and B cells. MHC II proteins present peptide antigens that originate extracellularly from foreign bodies such as bacteria. Proteins from the pathogen are degraded into peptide fragments within the APC, which sequesters these fragments into the endosome so they can bind to MHC class II proteins, before being transported to the cell surface. MHC class II receptors display antigens for recognition by helper T cells (stimulate development of B cell clones) and inflammatory T cells (cause the release of lymphokines that attract other cells to site of infection) . MHC class II molecules are comprised of two membrane-spanning chains, alpha (IPR001003 from INTERPRO) and beta, of similar size. Both chains consist of two globular domains (N- and C-terminal), and a transmembrane segment to anchor them to the membrane . A groove in the structure acts as the peptide-binding site. This entry represents the N-terminal domain (also called beta-1 domain) of the beta chain. ; GO: 0006955 immune response, 0016020 membrane; PDB: 1d5z_B 2seb_B 1d6e_B 1j8h_B 1d5m_B 1d5x_B 1ymm_B 1a6a_B 1jws_B 1sje_B .... Probab=100.00 E-value=9.9e-36 Score=214.31 Aligned_columns=74 Identities=43% Q ss_pred EEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCCCC Q ss_conf 78886-57996205899888757699999807777487017301403245068866977675420340037764125 Q Psfainz_l4 8 DRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGIWY 83 (84) Q Consensus 8 ~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv~y 83 (84) ++|+| |+|+ |||||.|+||||+|++|||||||||||+||+|+|+|++||+||++|+++||+||++|||||++++ T Consensus 1 ~~C~f~ngt~--~v~~i~r~iyNk~e~~rFdSdvG~fvg~Te~G~~~Ae~wN~~~~~l~~~ra~vd~~Cr~N~~~~~ 75 (75) T PF00969 1 SECYFSNGTE--RVRFIDRYIYNKEEYVRFDSDVGKFVGYTELGEKNAENWNSQKELLERKRAAVDTYCRHNYEIFE 75 (75) T ss_dssp EEEEEETTTT--EEEEEEEEEETTEEEEEEETTTTSEEESSGGGHHHHHHHHTSHHHHHHHHHHHHHTHHHHHHHHT T ss_pred CEEEECCCCC--CEEEEEEEEECCEEEEEECCCCCEEEEECHHHCHHHHHHCCCCCHHHHHHHHHCCCCCCEECCCC T ss_conf 9145406986--14898867776822688769986688401010101476278932332231000132011001249 No 14 >1ktd_B Fusion protein consisting of cytochrome C peptide, glycine rich linker, and MHC E-beta-K..., H-2 class II histocompatibility antigen, E-D alpha chain; HET: NAG; 2.40A {Columba livia and mus musculus} SCOP: b.1.1.2 d.19.1.1 Probab=99.97 E-value=8.7e-32 Score=193.22 Aligned_columns=81 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.++|||| |||+ +|||++||+||+++|++||||+|+|+|+||+|++.|+.||++|++|+++||.+|++|+||++ T Consensus 34 f~~~~~~~c~~~ngte--~vr~~~ry~Yngeefi~FDsd~g~~va~t~~g~~~a~~WN~~~~~le~~ra~le~~C~~n~~ 111 (215) T 1ktd_B 34 FLEYCKSECHFYNGTQ--RVRLLVRYFYNLEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYE 111 (215) T ss_dssp EEEEEEEEEEESSGGG--SEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHHCHHHHHHHHHHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCE--EEEEEEEEEECCEEEEEEECCCCEEECCCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHH T ss_conf 2478756789837953--78998655436102577807668797275455341565247778999886656544444444 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ++++ T Consensus 112 ~y~~ 115 (215) T 1ktd_B 112 IFDN 115 (215) T ss_dssp HHTT T ss_pred HHHH T ss_conf 4443 No 15 >d1k8ib2 d.19.1.1 (B:1-94) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), H2-DM} Probab=99.97 E-value=8.2e-32 Score=193.37 Aligned_columns=81 Identities=15% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEEC-----CCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 9303478788865799620589988875769999980777748701-----73014032450688669776754203400 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGY-----NEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~-----TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ||++|.+++|+|++++..+ +|+.|++|||+|++|||||||||||+ ||+|+++|++||++|++|+++||++|++| T Consensus 1 ~F~~~~~~~C~f~~~~~~~-~f~~s~~fNk~e~~~FdS~vgkfVg~e~~~~te~g~~~Ae~~N~~~~~l~~~ra~~d~~c 79 (94) T d1k8ib2 1 GFVAHVESTCVLNDAGTPQ-DFTYCVSFNKDLLACWDPDVGKIVPCEFGVLSRLAEIISNILNEQESLIHRLQNGLQDCA 79 (94) T ss_dssp CCEEEEEEEEEEESTTCEE-EECCEEEETTSCCEEEETTTTEEEECCCSTTHHHHHHHHHHHHTCHHHHHHHHHTHHHHH T ss_pred CEEEEEEEEEEECCCCCCC-EEEEEEEECCEEEEEECCCCCEEECCCCEECCHHHHHHHHHCCCCHHHHHHHHHHHHHHH T ss_conf 9058878788871899700-378999767778888979776686010110053111566742898779999988888887 Q ss_pred CCCCCCC Q ss_conf 3776412 Q Psfainz_l4 76 QHNIGIW 82 (84) Q Consensus 76 rhN~gv~ 82 (84) |||++++ T Consensus 80 ~~n~~~~ 86 (94) T d1k8ib2 80 THTQPFW 86 (94) T ss_dssp HHHHHHH T ss_pred HHHHHHH T ss_conf 6300000 No 16 >d1k8ib2 d.19.1.1 (B:1-94) Class II MHC beta chain, N-terminal domain {Mouse (Mus musculus), H2-DM} Probab=99.95 E-value=2.4e-29 Score=180.16 Aligned_columns=81 Identities=15% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEEC-----CCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 9303478788865799620589988875769999980777748701-----73014032450688669776754203400 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGY-----NEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~-----TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ||++|.+++|+|++++.++ +|+.|++|||+|+++||||+|+|||+ ||+|+++|++||++|++|+++||++|++| T Consensus 1 ~F~~q~~~~C~~~~~~~~~-~f~~~~~yN~~e~i~Fds~~g~fv~~e~~~~t~~g~~~A~~wN~~~~~l~~~r~~~~~~c 79 (94) T d1k8ib2 1 GFVAHVESTCVLNDAGTPQ-DFTYCVSFNKDLLACWDPDVGKIVPCEFGVLSRLAEIISNILNEQESLIHRLQNGLQDCA 79 (94) T ss_dssp CCEEEEEEEEEEESTTCEE-EECCEEEETTSCCEEEETTTTEEEECCCSTTHHHHHHHHHHHHTCHHHHHHHHHTHHHHH T ss_pred CEEEEEEEEEEECCCCCEE-EEEEEEEECCEEEEEECCCCCEEECCCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH T ss_conf 9278878788861899612-688998667767788959777897255311356667888751798889999988888787 Q ss_pred CCCCCCC Q ss_conf 3776412 Q Psfainz_l4 76 QHNIGIW 82 (84) Q Consensus 76 rhN~gv~ 82 (84) |||++.+ T Consensus 80 r~~~~~~ 86 (94) T d1k8ib2 80 THTQPFW 86 (94) T ss_dssp HHHHHHH T ss_pred HHHHCCC T ss_conf 6520021 No 17 >1lnu_B H-2 class II histocompatibility antigen, A beta chain, H-2 class II histocompatibility antigen, A-B alpha chain; HET: NAG; 2.50A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 Probab=99.95 E-value=4.6e-28 Score=173.34 Aligned_columns=81 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |+++.+.+|+| |||+ +|||+.||+||+++|++||||+|+|+|+|++|++.|+.||++|++||+.||.+|++|+||+. T Consensus 33 f~~q~~~~C~~~ngt~--~Vr~v~ry~Ydgedfi~FDsd~g~~va~t~~a~~~a~~WNs~~~~le~~ra~le~~C~~n~~ 110 (217) T 1lnu_B 33 FVYQFMGECYFTNGTQ--RIRYVTRYIYNREEYVRYDSDVGEHRAVTELGRPDAEYWNSQPEILERTRAELDTVCRHNYE 110 (217) T ss_dssp CEEEEEEEEECCTTTT--SCEEEEEEEETTEEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHTTHHHHTTHHHHH T ss_pred HEEEEEEEEEEECCCE--EEEEEEEEEECCHHEEEECCCCCEEECCCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHC T ss_conf 5356664258708942--78998666654014466616468797188689888876324178999885234443321100 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ...+ T Consensus 111 ~~~~ 114 (217) T 1lnu_B 111 GPET 114 (217) T ss_dssp TTTT T ss_pred CCCC T ss_conf 0012 No 18 >1ktdB01 3.10.320.10 Probab=99.93 E-value=4.8e-26 Score=162.54 Aligned_columns=82 Identities=45% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|+.+.+.+|+| |+++ +|+++.+++||++++++|||++|+|+|+||+|++.|+.||+++++|++.||++|++||||+ T Consensus 33 ~f~~~~~~~C~~~~~~~--~~~~~~~~~yn~~~~~~f~s~~G~~~~~t~~G~~~A~~~n~~~~~l~~~~~~~~~~C~~~~ 110 (118) T 1ktdB01 33 GFLLYLKSECHFSNGTE--RVRYLDRYIYNREEYVRFDSDVGKYVGVTELGVKNAEYWNSDKELLEQLRAEVDTYCRHNY 110 (118) T ss_pred CEEEEEEEEEEEECCCC--CEEEEEEECCCCEEEEEECCCCCEEEEECCCCHHHHHHCCCCHHHHHHHHHHHHCCCCCCC T ss_conf 12455443225515866--2455331002724678870887517631500124454227866688877654301133443 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 111 ~~~~~ 115 (118) T 1ktdB01 111 GVLES 115 (118) T ss_pred CCCCC T ss_conf 33331 No 19 >1fne_B MHC class II I-EK, beta chain; histocompatibility antigen, peptide, immune system; HET: NAG; 1.90A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 PDB: 1fng_B* 1iea_B* 1i3r_B* 1ieb_B* 1kt2_B* 1r5v_B 1r5w_B 2fse_B 1ymm_B* 1d5z_B* 1d5x_B* 1d6e_B* 2seb_B* 1a6a_B* 1d5m_B* 1j8h_B* 1fyt_B* 1seb_B 1bx2_B* 1zgl_B 1fv1_B 1h15_B* 1hqr_B Probab=99.91 E-value=2.1e-24 Score=153.80 Aligned_columns=81 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.+.+|+| |||+ +|+|+.||+||+++|++||||+|+|+|+|++|++.|+.||++++++++.|+.++++|+||+. T Consensus 33 fl~q~~~eC~f~nGt~--~vr~~~ry~YdGeefl~FDsd~g~~va~t~~a~~~a~~wn~~~~~l~~~r~~l~~~C~~~~~ 110 (224) T 1fne_B 33 FLEYCKSECHFYNGTQ--RVRLLVRYFYNLEENLRFDSDVGEFRAVTELGRPDAENWNSQPEFLEQKRAEVDTVCRHNYE 110 (224) T ss_dssp EEEEEEEEEEESSGGG--SEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHCCCCHHHHHHHHHHHHEEEECCCC T ss_conf 8999866799826960--79999767764220888836567798278789888754057257888766543100000100 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ...+ T Consensus 111 ~~~~ 114 (224) T 1fne_B 111 IFDN 114 (224) T ss_dssp HHTT T ss_pred CCHH T ss_conf 0000 No 20 >d1hdmb2 d.19.1.1 (B:3-87) Class II MHC beta chain, N-terminal domain {Human (Homo sapiens), HLA-DM} Probab=99.89 E-value=4.2e-23 Score=146.82 Aligned_columns=78 Identities=12% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |++|.+++|+| |+++ .++|+.+++||++++++|||++|+|||+||+|+++|+.||++|++|+ ++..+++.|+||++ T Consensus 1 f~~~~~~~C~~~~dg~--~~~f~~~~~yng~~~~~fds~~~~~va~t~~a~~~a~~wN~~~~~~~-~~~~~~~c~~~~~~ 77 (85) T d1hdmb2 1 FVAHVESTCLLDDAGT--PKDFTYCISFNKDLLTCWDPEENKMAPCNSLANVLSQHLNQKDTLMQ-RLNGLQNCATHTQP 77 (85) T ss_dssp CEEEEEEEEEEETTSC--EEEEEEEEEETTEEEEEEETTTTEEEECCHHHHHHHHHHHTCHHHHH-HCCHHHHHHHHHTT T ss_pred CEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCCEEEECCHHHHHHHHHHCCCHHHHH-HHHHHHHHHHHHHH T ss_conf 9578677788658993--45788988775656788828777898168788889887068788999-99986258887676 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) ++ T Consensus 78 ~~ 79 (85) T d1hdmb2 78 FW 79 (85) T ss_dssp TH T ss_pred HH T ss_conf 44 No 21 >1a6aB01 3.10.320.10 Probab=99.88 E-value=1e-22 Score=144.79 Aligned_columns=82 Identities=45% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|+.+.+.+|+| ++++ +|+++.+++||+.++++|||++|+|+|+|++|++.|+.||++++.|+..|+++|++|+||+ T Consensus 2 ~f~~~~~~~c~~~~~~~--~~~~~~~~~~n~~~~~~f~s~~G~~~~~t~~G~~~a~~~n~~~~~l~~~~~~~~~~C~~~~ 79 (89) T 1a6aB01 2 GFLLLLKSECLFSNGTE--DVRYLDRYIYNREEYVRFDSDVGKYVGVTELGVKNAEYWNSDKELLEQLRAEVDTYCRHNY 79 (89) T ss_pred CCEEEEEEEEEECCCCC--CEEEEEECCCCCEEEEEECCCCCCEEECCCCCHHHHHHCCCCHHHHHHHHHHHHCCCCCCC T ss_conf 41134545556505765--2222110002623478760887604310411202233226865688877654310022332 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 80 ~~~~~ 84 (89) T 1a6aB01 80 GVLES 84 (89) T ss_pred CCCCC T ss_conf 10010 No 22 >2bc4_B HLA class II histocompatibility antigen, DM beta chain; HET: NAG MAN; 2.27A {Homo sapiens} PDB: 1hdm_B 1k8i_B* Probab=99.82 E-value=2.9e-20 Score=131.62 Aligned_columns=81 Identities=15% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEE-----CCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 930347878886579962058998887576999998077774870-----173014032450688669776754203400 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVG-----YNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg-----~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ||++|.+++|.++..+ +...|..+++|||+++++|||++|+|++ +|++|++.|+.||+++++||++||.+++.| T Consensus 2 gfv~~~~~~Cel~~dg-s~~~f~~~~~fNk~~l~~FDs~~g~~v~~e~~a~~~~a~~~a~~wN~~~~~~e~~k~~~~~c~ 80 (211) T 2bc4_B 2 GFVAHVESTCLLDDAG-TPKDFTYCISFNKDLLTCWDPEENKMAPCEFGVLNSLANVLSQHLNQKDTLMQRLRNGLQNCA 80 (211) T ss_dssp -CEEEEEEEEEEETTC-CEEEEEEEEEETTEEEEEEETTTTEEEECCCSTTHHHHHHHHHHHHTCHHHHHHHHTHHHHHH T ss_pred CEEEEEEEEEEECCCC-CCCEEEEEEEECCEEEEEECCCCCEEEEEEEEEECHHHHHHHHHHCCCHHHHHHHHHHHHHHH T ss_conf 1589985466874898-802079998648778898847526886446576141357888862388779998862346667 Q ss_pred CCCCCCC Q ss_conf 3776412 Q Psfainz_l4 76 QHNIGIW 82 (84) Q Consensus 76 rhN~gv~ 82 (84) +||++.+ T Consensus 81 ~~~~~~~ 87 (211) T 2bc4_B 81 THTQPFW 87 (211) T ss_dssp HHHHHHH T ss_pred HHHHCCC T ss_conf 6531001 No 23 >1iao_B MHC class II I-AD; MHC II, class II MHC, ovalbumin peptide; HET: NAG; 2.6A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 Probab=99.78 E-value=7.2e-19 Score=124.16 Aligned_columns=81 Identities=28% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+.+|+| |+|+ .|+|+.||+||++++++|||++|+|+|++++|++.|+.||++++++++.++.++++|+++.. T Consensus 32 fv~Q~~~gC~~~~gt~--~v~f~~ryaYDGedfi~FDsd~g~wva~t~~a~~ta~~Wns~~~~le~~~~~le~~C~~~~~ 109 (222) T 1iao_B 32 FVVQFKGECYYTNGTQ--RIRLVTRYIYNREEYVRYDSDVGEYRAVTELGRPDAEYWNSQPEILDRTRAEVDTACRHNYE 109 (222) T ss_dssp CEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHHCHHHHHHHHTHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHCCCCEEEEEE T ss_conf 5999977689837984--78999888774734788815556685187478777766642334677877502431000000 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ..+. T Consensus 110 ~~~~ 113 (222) T 1iao_B 110 GPET 113 (222) T ss_dssp TTGG T ss_pred CCCC T ss_conf 1112 No 24 >SUPFAM0021708 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1ktdb2. Probab=99.75 E-value=2.9e-18 Score=120.95 Aligned_columns=82 Identities=33% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+..|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++.+++.|+.++++|+||+ T Consensus 33 ~~~~~~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~fd~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 110 (120) T SUPFAM0021708 33 SHTLQRMYGCEFGNDTG--DVRGLDQYAYNGEDFIRFDSDVGTWVAVTELAVITAEKWNSDKALLEQLRAYLETYCRENL 110 (120) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 45888888788707986--0445433210762246770755268732388899998614646799999988863408888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 111 ~~~~~ 115 (120) T SUPFAM0021708 111 KKYLE 115 (120) T ss_pred HHHHH T ss_conf 88875 No 25 >SUPFAM0022344 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1mhca2. Probab=99.75 E-value=4.7e-18 Score=119.82 Aligned_columns=81 Identities=28% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+.+|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||+++ .+++.|+.++++|+||+ T Consensus 92 ~~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~C~~~~ 168 (181) T SUPFAM0022344 92 PHTLQVKYGCELLNGGE--LVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAQKTAEKWNSDK-LLEQLRAYLETYCRENL 168 (181) T ss_pred CEEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCEEEEECCHHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHH T ss_conf 47999998889836995--5789988876585889995574089865778999999832435-89999998865778998 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 169 ~~~~~ 173 (181) T SUPFAM0022344 169 KRYLE 173 (181) T ss_pred HHHHH T ss_conf 88865 No 26 >SUPFAM0024281 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1zaga2. Probab=99.74 E-value=5.9e-18 Score=119.28 Aligned_columns=82 Identities=28% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 93034787888657996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) .|..+.+..|++++.+ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++++++.|+.++++|+||++ T Consensus 90 ~~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C~~~~~ 167 (179) T SUPFAM0024281 90 PHTLQVKYGCELNNGG--RVRGFWRYAYNGEDFLRFDSDVGTWVAVTELAQITAEKWNSDKELLEQLRAYLETYCRENLG 167 (179) T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHH T ss_conf 5689999999983797--07899888756758899955642797377889999998305688999999987658789888 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..+ T Consensus 168 ~~~~ 171 (179) T SUPFAM0024281 168 KYLE 171 (179) T ss_pred HHHH T ss_conf 8876 No 27 >SUPFAM0020368 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1i3rb2. Probab=99.74 E-value=7e-18 Score=118.89 Aligned_columns=82 Identities=29% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+..|++ ++++ +++++.+++||++++++||||+|+++|+|++|++.|+.||++++.+++.|+.++++|+||+ T Consensus 32 ~~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 109 (120) T SUPFAM0020368 32 SHTLQVMYGCELLSDGS--LVRGFDQYAYNGEDFLRFDSDVGTWVAATELARITAEKWNSDKGLLEQLRAYLETYCRENL 109 (120) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 55899999899738985--2568988877585788881764168607789999999714758899999998754879998 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 110 ~~~~~ 114 (120) T SUPFAM0020368 110 RKYLE 114 (120) T ss_pred HHHHH T ss_conf 88877 No 28 >SUPFAM0018766 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1exua2. Probab=99.74 E-value=8.4e-18 Score=118.45 Aligned_columns=82 Identities=28% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 93034787888657996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) .|..+.+..|++|+++ .++++.+++||++++++|||++|+++|+|++|++.|+.||++++.+++.|+.++++|+||++ T Consensus 84 ~~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~ 161 (173) T SUPFAM0018766 84 PHTLQVKSGCELNSDG--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAQITAEKWNSDKGLLEQLRAYLEGTCRENLG 161 (173) T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHH T ss_conf 6699999999987996--48999988766847899955641798466789999998226788999999887558899888 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ++.+ T Consensus 162 ~~~~ 165 (173) T SUPFAM0018766 162 RYLE 165 (173) T ss_pred HHHH T ss_conf 8875 No 29 >SUPFAM0021906 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1ld9a2. Probab=99.74 E-value=6.2e-18 Score=119.17 Aligned_columns=80 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+..|++ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++ +++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~-~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0021906 93 HTLQVMYGCELTNDGS--RVRGFWRYAYNGEEFLRFDSDVGKWVAVTELAQKTAEKWNSDKE-LEQLRAYLETTCRENLG 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCEEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHHH T ss_conf 7999999999837970--57899888764758899855621898556789999998347378-99999988658899998 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ++.+ T Consensus 170 ~~~~ 173 (181) T SUPFAM0021906 170 IYLE 173 (181) T ss_pred HHHH T ss_conf 8875 No 30 >SUPFAM0016542 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1agda2. Probab=99.73 E-value=1.1e-17 Score=117.76 Aligned_columns=81 Identities=30% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+.+|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++ +++.|+.++++|+||+ T Consensus 92 ~~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~-~~~~~~~~~~~C~~~~ 168 (181) T SUPFAM0016542 92 PHTLQVKYGCELLNDGS--LVRGFWRYAYNGEDFLRFDSDVGTWVAVTELGVITAEKWNSDKA-LEQLRAYLETYCRENL 168 (181) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHH T ss_conf 47999999999837981--46788888865858999946742798637889999998347567-9999998876879998 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 169 ~~~~~ 173 (181) T SUPFAM0016542 169 KRYLE 173 (181) T ss_pred HHHHH T ss_conf 88875 No 31 >SUPFAM0023693 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1qqda2. Probab=99.72 E-value=1.7e-17 Score=116.79 Aligned_columns=81 Identities=31% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+.+|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++ +++.|+.++++|+||+ T Consensus 91 ~~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~w~~~~~-~~~~~~~~~~~C~~~~ 167 (180) T SUPFAM0023693 91 PHTLQVKYGCELLNDGS--LVRGFLRYAYNGEDFLRFDSDVGTWVAVTELGVITAEKWNSDKE-LEQLRAYLETYCRENL 167 (180) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHH T ss_conf 47999998888848981--46789888766747899836764798556889999998415467-9999998854768888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 168 ~~~~~ 172 (180) T SUPFAM0023693 168 GRYLE 172 (180) T ss_pred HHHHH T ss_conf 77764 No 32 >SUPFAM0016328 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1a1na2. Probab=99.72 E-value=1.7e-17 Score=116.81 Aligned_columns=81 Identities=27% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+.+|++ +++. +++++.+++||++++++||||+|+|+|+|++|++.|+.||++++ +++.|+.++++|+||+ T Consensus 92 ~~~~q~~~~c~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~-~~~~~~~~~~~C~~~~ 168 (181) T SUPFAM0016328 92 PHTLQVKYGCELTNDGS--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAQITAEKWNSDKE-LEQLRAYLETYCRENL 168 (181) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHH T ss_conf 47999999999847981--45788888756837899845665798557899999998415578-9999998866879988 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 169 ~~~~~ 173 (181) T SUPFAM0016328 169 RKYLE 173 (181) T ss_pred HHHHH T ss_conf 88764 No 33 >SUPFAM0022030 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1lnub2. Probab=99.71 E-value=3.2e-17 Score=115.36 Aligned_columns=82 Identities=28% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+..|++ ++++ .++++.+++||++++++|||++|+++|+|++|++.|+.||++++.+++.|+.++++|++|+ T Consensus 32 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 109 (120) T SUPFAM0022030 32 SHTLQVMYGCELLNDTG--LVRGFLQYAYNGEDFLRFDSDVGEWVAVTELAQITAEKWNSDKGLLEQLRAYLETTCRENL 109 (120) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 46899888888727986--0247888877585778882665268645578999999832637899999998841658888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 110 ~~~~~ 114 (120) T SUPFAM0022030 110 QKYLE 114 (120) T ss_pred HHHHH T ss_conf 77654 No 34 >SUPFAM0019868 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1gzqa2. Probab=99.71 E-value=4.3e-17 Score=114.66 Aligned_columns=81 Identities=30% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEE-CCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870-17301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVG-YNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg-~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+.+|++++.+ .++++.+++||++++++|||++|+++| +|++|++.|+.||++++.+++.|+.++++|++|++ T Consensus 92 ~~~q~~~~C~~~~~~--~~~~~~~~~~~g~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0019868 92 HTLQVKYGCEFNNGG--RVRGFWRYAYNGEDFLRFDSDVGTWVAEVTELAVITAEKWNSDKDLLEQLRAYLETYCRENLK 169 (181) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHH T ss_conf 589999999983897--489987766477689999745427950776689999998216588999999876338899887 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ++.+ T Consensus 170 ~~~~ 173 (181) T SUPFAM0019868 170 KYLE 173 (181) T ss_pred HHHH T ss_conf 7752 No 35 >SUPFAM0020968 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1je6a2. Probab=99.71 E-value=4.1e-17 Score=114.80 Aligned_columns=82 Identities=27% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECC-----CCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 93034787888657996205899888757699999807777487017-----3014032450688669776754203400 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYN-----EVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~T-----elG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .|..+.+.+|++++.+ +++++.+++||++++++|||++|+++|+| ++|++.|+.||++++.+++.|+.++++| T Consensus 88 ~~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C 165 (181) T SUPFAM0020968 88 PHTLQVKYGCELNNGG--LVRGFERYAYNGEDFLRFDSDVGTWVAVTSPEAGELAQKTAEKWNSDKELLEQLRAYLETYC 165 (181) T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCHHHHHHHHHHCCCHHHHHHHHHHHHHHH T ss_conf 5589999999984897--06899888766768999955741798516665306789999984044889999998873387 Q ss_pred CCCCCCCCC Q ss_conf 377641259 Q Psfainz_l4 76 QHNIGIWYS 84 (84) Q Consensus 76 rhN~gv~yS 84 (84) +|++..+.. T Consensus 166 ~~~~~~~~~ 174 (181) T SUPFAM0020968 166 REWLKKYLN 174 (181) T ss_pred HHHHHHHHH T ss_conf 999998864 No 36 >SUPFAM0019307 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1fv1b2. Probab=99.70 E-value=6e-17 Score=113.91 Aligned_columns=82 Identities=33% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ ++++ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++.++..|+.++++|+||+ T Consensus 6 ~~~~~~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 83 (92) T SUPFAM0019307 6 GHTLQVMYGCELNSDGS--RVRGFDQYAYNGEDFLRFDSDVGEWVAVTELAVITAEKWNSDKGLLEQLRAYLETYCRHNL 83 (92) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCEEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 25899988888747984--2578887765583678882873078615478888898714647789999887765768887 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 84 ~~~~~ 88 (92) T SUPFAM0019307 84 KKYLE 88 (92) T ss_pred HHHHH T ss_conf 76753 No 37 >SUPFAM0018419 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1ed3a2. Probab=99.70 E-value=4.2e-17 Score=114.72 Aligned_columns=80 Identities=31% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+..|++ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~~~~~~c~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0018419 93 HTLQVKYGCELSNDGS--RVRGFWRYAYNGEDFLRFDSDVGTWVAVTELAVKTAEKWNSD-GLLEQLRAYLETYCRENLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999999837970--556787777567478998456637986378999999870752-6899999988768899999 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..+ T Consensus 170 ~~~~ 173 (181) T SUPFAM0018419 170 KYLE 173 (181) T ss_pred HHHH T ss_conf 8875 No 38 >SUPFAM0017423 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1cd1a2. Probab=99.70 E-value=6.1e-17 Score=113.87 Aligned_columns=82 Identities=30% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCC-CCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886579962058998887576999998077774870173-0140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNE-VGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~Te-lG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+..|++++.+ .++++.+++||++++++|||++|+++|+|+ +|++.|+.||++++.+++.|+.++++|+||+ T Consensus 89 ~~~~q~~~~C~~~~~~--~~~~~~~~~~~g~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 166 (179) T SUPFAM0017423 89 PHTLQVKYGCELNNGG--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTESLGQKTAEKWNSDKALLEQLRAYLETYCRHNL 166 (179) T ss_pred CEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH T ss_conf 4689999999983897--68999877647836789855641786555367788998840358899999988877879999 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 167 ~~~~~ 171 (179) T SUPFAM0017423 167 KKYLE 171 (179) T ss_pred HHHHH T ss_conf 88875 No 39 >SUPFAM0021412 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1k8da2. Probab=99.70 E-value=5.2e-17 Score=114.23 Aligned_columns=80 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+.+|++ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0021412 93 HTLQVKYGCELSNDGS--LVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAVITAEKWNSD-GLLEQLRAYLETYCRHNLG 169 (181) T ss_pred EEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999889837970--577887777667578998456517986377899999981650-5899999988658799998 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) ++.+ T Consensus 170 ~~~~ 173 (181) T SUPFAM0021412 170 KYLE 173 (181) T ss_pred HHHH T ss_conf 8875 No 40 >1uvq_B HLA class II histocompatibility antigen; HET: NAG FUC BMA; 1.8A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1jk8_B* 1s9v_B 2iad_B 1muj_B* 1d9k_D* 1iak_B* 1jl4_B 1f3j_B* 1k2d_B* 1u3h_D 1aqd_B 1klu_B 1jwm_B 1jws_B 1hxy_B 1klg_B 1jwu_B 1lo5_B 1pyw_B 1r5i_B 1sje_B 1sjh_B 1t5w_B 1t5x_B 2g9h_B* 2icw_B 2ipk_B* 2oje_B 1kg0_B 1dlh_B Probab=99.70 E-value=7.7e-17 Score=113.31 Aligned_columns=79 Identities=28% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |.++.+.+|+| |||+ +|+|+.+|.||+++|+.||++.+.++|.++.|.+.|+.||++++.+++.++..++.|.+++. T Consensus 5 fv~Q~~~~C~~~ngte--~v~fv~~y~YDG~Dfi~fD~d~~~w~a~~~~a~~~k~~w~~~~~~~~~~k~~Le~~C~~~l~ 82 (198) T 1uvq_B 5 FVFQFKGMCYFTNGTE--RVRLVTRYIYNREEYARFDSDVGVYRAVTPQGRPDAEYWNSQKEVLEGTRAELDTVCRHNYE 82 (198) T ss_dssp CEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSGGGHHHHHHHHTCHHHHHHHHHHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCE--EEEEEEEEEECCEEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHHEEEEHHCC T ss_conf 1575764168747961--58899878872342788717667797188678899987635788886454433112100000 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) .. T Consensus 83 ~~ 84 (198) T 1uvq_B 83 VA 84 (198) T ss_dssp HT T ss_pred CC T ss_conf 10 No 41 >SUPFAM0017254 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1bx2b2. Probab=99.70 E-value=7.3e-17 Score=113.43 Aligned_columns=82 Identities=30% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) ++..+.+..|++ ++++ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++.++..|+.++++|+||+ T Consensus 4 ~~~~~~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 81 (90) T SUPFAM0017254 4 GHTLQVMYGCELNNDGS--RVRGFDQYAYNGEDFLRFDSDVGEWVAVTELAVITAEKWNSDKGLLERLRAYLEGYCRENL 81 (90) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCEEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 35889998888847984--1568988876584778882863078625578988998723646789999987632658888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 82 ~~~~~ 86 (90) T SUPFAM0017254 82 QKYLE 86 (90) T ss_pred HHHHH T ss_conf 87753 No 42 >SUPFAM0022711 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1neza2. Probab=99.70 E-value=6.3e-17 Score=113.79 Aligned_columns=78 Identities=32% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+..|++ +++. +++++.+++||++++++|||++|+++|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0022711 93 HTLQVKYGCELLNDGS--DVRGFLRYAYNGEDFLRFDSDVGKWVAATELAVITAEKWNSD-GLLEQLRAYLETTCRENLR 169 (181) T ss_pred EEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999999737981--357888776567578999657307985567899999870761-6899999987668899998 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) +. T Consensus 170 ~~ 171 (181) T SUPFAM0022711 170 RY 171 (181) T ss_pred HH T ss_conf 88 No 43 >SUPFAM0017778 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1d5mb2. Probab=99.69 E-value=7.9e-17 Score=113.27 Aligned_columns=82 Identities=30% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ ++++ +++++.+++||++++++|||++|+++|+|++|++.|+.||+++++++..|+.++++|+||+ T Consensus 5 ~~~~~~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 82 (91) T SUPFAM0017778 5 GHTLQVMYGCELLSDGS--RVRGFDQYAYNGEDFLRFDSDVGEWVAVTELAQITAEKWNSDKGLLERLRAYLETYCRENL 82 (91) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCEEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 36899888888737984--1457887765683568881863078626468888888722537789999988754658888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 83 ~~~~~ 87 (91) T SUPFAM0017778 83 QKYLE 87 (91) T ss_pred HHHHH T ss_conf 77763 No 44 >SUPFAM0022346 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1mhea2. Probab=99.69 E-value=6e-17 Score=113.91 Aligned_columns=80 Identities=31% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+..|++ |++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 92 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 168 (180) T SUPFAM0022346 92 HTLQVMYGCELLNDGS--LVRGFWRYAYNGEDFLRFDSDVGTWVAVTELAVITAEKWNSD-GLLEQLRAYLETYCRENLK 168 (180) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999999837971--678887787667578998356637986378999999870742-6899999987558899999 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..+ T Consensus 169 ~~~~ 172 (180) T SUPFAM0022346 169 KYLE 172 (180) T ss_pred HHHH T ss_conf 8875 No 45 >SUPFAM0021478 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1kcgc_. Probab=99.69 E-value=7.4e-17 Score=113.42 Aligned_columns=79 Identities=32% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400377641 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGI 81 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv 81 (84) +..+.+..|++++.+ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++.+++.|+.++++|+||++. T Consensus 91 ~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C~~~~~~ 168 (178) T SUPFAM0021478 91 HTLQVKYGCELSNGG--RVRGFDRYAYNGEDFLRFDSDLGTWVAVTELGVITAEKWNSDKELLEQLRAYLETECRENLGR 168 (178) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHH T ss_conf 689999999983797--078887666556578998455537985368899999971265889999999875588999999 Q ss_pred C Q ss_conf 2 Q Psfainz_l4 82 W 82 (84) Q Consensus 82 ~ 82 (84) . T Consensus 169 ~ 169 (178) T SUPFAM0021478 169 Y 169 (178) T ss_pred H T ss_conf 9 No 46 >SUPFAM0018220 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1e27a2. Probab=99.69 E-value=6.7e-17 Score=113.63 Aligned_columns=80 Identities=31% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+..|++ |++. +++++.+++||++++++|||++|+++|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0018220 93 HTLQVKYGCELSNDGS--RVRGFWRYAYNGEDFLRFDSDVGTWVAATELAVITAEKWNSD-GLLEQLRAYLETYCRHNLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999999827970--577887777567478998556537986488999999870744-7899999987548789999 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) +..+ T Consensus 170 ~~~~ 173 (181) T SUPFAM0018220 170 KYLE 173 (181) T ss_pred HHHH T ss_conf 8874 No 47 >SUPFAM0016399 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1a6ab2. Probab=99.69 E-value=1.1e-16 Score=112.49 Aligned_columns=82 Identities=33% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ ++++ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++.++..|+.++++|+||+ T Consensus 2 ~~~~~~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 79 (88) T SUPFAM0016399 2 GHTLQVMYGCELNNDGS--DVRGFDQYAYNGEDFLRFDSDVGEWVAVTELAVITAEKWNSDKGLLEQLRAYLETYCRENL 79 (88) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEECCCCEEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 45889998888847985--1468998877584788881874078735578888888723647789999988765888888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 80 ~~~~~ 84 (88) T SUPFAM0016399 80 QKYLE 84 (88) T ss_pred HHHHH T ss_conf 77752 No 48 >SUPFAM0018120 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1duza2. Probab=99.69 E-value=8.6e-17 Score=113.07 Aligned_columns=78 Identities=31% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |..+.+..|++ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~q~~~~c~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0018120 93 HTLQVKYGCELSNDTS--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAVITAEKWNSD-GLLEQLRAYLETYCRENLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 6888888999827971--566888777557478998456627986378999999870734-7999999987548799999 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) .. T Consensus 170 ~~ 171 (181) T SUPFAM0018120 170 KY 171 (181) T ss_pred HH T ss_conf 99 No 49 >SUPFAM0021063 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1jk8b2. Probab=99.68 E-value=1.7e-16 Score=111.46 Aligned_columns=82 Identities=28% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ +++. +++++.+++||++++++||||+|+++++|++|++.|+.||+++++++..|+.++++|++|+ T Consensus 4 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 81 (92) T SUPFAM0021063 4 SHTLQRMYGCELLNDGS--LVRGFLQYAYNGEDFLRFDSDVGEWVAVTELAQITAEKWNSDKGLLERLRAYLEGTCRENL 81 (92) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 35889998999827985--1468998877683789981774168636778988998722547789999987621668988 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 82 ~~~~~ 86 (92) T SUPFAM0021063 82 RKYLE 86 (92) T ss_pred HHHHH T ss_conf 87765 No 50 >SUPFAM0016670 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1aqdb2. Probab=99.67 E-value=2.2e-16 Score=110.83 Aligned_columns=82 Identities=29% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .+..+.+..|++ ++++ +++++.+++||++++++|||++|+++|.|++|++.|+.||++++.++..|+.++++|++|+ T Consensus 3 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 80 (89) T SUPFAM0016670 3 SHTLQVMYGCELLNDGS--LVRGFLQYAYNGEDFLRFDSDVGKWVAATELAEITAEKWNSDKGLLERLRAYLEGYCRENL 80 (89) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 36889998899848996--0368998877683678881764178626668888888713756689999987644778888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 81 ~~~~~ 85 (89) T SUPFAM0016670 81 RKYLE 85 (89) T ss_pred HHHHH T ss_conf 77752 No 51 >SUPFAM0021571 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1kjva2. Probab=99.67 E-value=1.7e-16 Score=111.43 Aligned_columns=78 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+..|.+ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||+. T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~y~~~~~~~f~~~~~~~~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0021571 93 HTLQVMYGCELTNDGS--RVRGFLRYAYNGEDFLRFDSDVGTWVAATELGVITAEKWNSD-GLLEQLRAYLETTCRHNLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999999888748970--577887666567478998456517985476789999870735-7999999887668899999 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) +. T Consensus 170 ~~ 171 (181) T SUPFAM0021571 170 KY 171 (181) T ss_pred HH T ss_conf 98 No 52 >SUPFAM0020991 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1jfma_. Probab=99.67 E-value=2.2e-16 Score=110.88 Aligned_columns=80 Identities=26% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400377641 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGI 81 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv 81 (84) +..+.+..|++++.+ +++++.+++||++++++|||++|+++|+|++|++.|+.||+++ .++..|+.++++|+||+++ T Consensus 90 ~~~q~~~~C~~~~~~--~~~~~~~~~~~g~~~~~f~~~~~~~~~~~~~~~~~~~~w~~~~-~~~~~~~~~~~~C~~~~~~ 166 (174) T SUPFAM0020991 90 HTLQVKYGCELNNGG--RVRGFWRYAYNGEDFLRFDSDVGEWVAVTELAVITAEKWNSDK-LLEQLRAYLEGTCRENLKK 166 (174) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCEEEEECCHHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 689999999984897--1799988875776899995673079616588999999834634-7999999875688999988 Q ss_pred CCC Q ss_conf 259 Q Psfainz_l4 82 WYS 84 (84) Q Consensus 82 ~yS 84 (84) +.. T Consensus 167 ~~~ 169 (174) T SUPFAM0020991 167 YLE 169 (174) T ss_pred HHH T ss_conf 763 No 53 >SUPFAM0024494 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d2iadb2. Probab=99.66 E-value=2.9e-16 Score=110.24 Aligned_columns=82 Identities=28% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ +++. +++++.+++||++++++|||++|++++.|++|++.|+.||++++.++..|+.++++|++|+ T Consensus 2 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 79 (89) T SUPFAM0024494 2 SHTLQVMYGCELLNDGS--LVRGFLQYAYNGEDFLRFDSDVGEWVAVTELAQITAEKWNSDKGLLERLRAYLETTCRENL 79 (89) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 45889998899848995--1468998877682678880775268526568888888713647799999988765889988 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 80 ~~~~~ 84 (89) T SUPFAM0024494 80 RKYLE 84 (89) T ss_pred HHHHH T ss_conf 88875 No 54 >SUPFAM0020165 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1hoca2. Probab=99.66 E-value=4.1e-16 Score=109.44 Aligned_columns=81 Identities=30% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCC-- Q ss_conf 930347878886-57996205899888757699999807777487017301403245068866977675420340037-- Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQH-- 77 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~Crh-- 77 (84) .|..+.+.+|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++ +++.|+.++++|+| T Consensus 92 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~C~~~l 168 (181) T SUPFAM0020165 92 PHTLQVKSGCELLNDGS--LVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAVKTAEKWNSDKA-LEQLRAYLETYCREWL 168 (181) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHH T ss_conf 57999998889847982--35789888765847899846741798545889999998437557-9999998866889988 Q ss_pred -CCCCCCC Q ss_conf -7641259 Q Psfainz_l4 78 -NIGIWYS 84 (84) Q Consensus 78 -N~gv~yS 84 (84) |+....+ T Consensus 169 ~~~~~~~~ 176 (181) T SUPFAM0020165 169 KNYLEYGK 176 (181) T ss_pred HHHHHHCH T ss_conf 87643000 No 55 >SUPFAM0020207 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1hsaa2. Probab=99.66 E-value=3.3e-16 Score=109.92 Aligned_columns=78 Identities=29% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+..|.+ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++++ +++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~w~~~~~~~~~~~~~w~~~~~-~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0020207 93 HTLQVKYGCELTNDGS--RVRGFDRYAYNGEDFLRFDSDVGTWVAVTELGVITAEKWNSDKD-LEQLRAYLEGTCRHNLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHHHHHH T ss_conf 7899999988737961--57788777656737899835653798456467899997235278-99999988778899999 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) +. T Consensus 170 ~~ 171 (181) T SUPFAM0020207 170 KY 171 (181) T ss_pred HH T ss_conf 88 No 56 >SUPFAM0016837 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1b3ja2. Probab=99.65 E-value=5e-16 Score=108.96 Aligned_columns=79 Identities=29% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCC-----CHHHCCCCHHHHHHHHHHHCCCCC Q ss_conf 303478788865799620589988875769999980777748701730140-----324506886697767542034003 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVK-----QAEAWNKDQGQLAVWRAQKETYCQ 76 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~-----~Ae~wN~~~~~Le~~Ra~vdt~Cr 76 (84) +..+.+..|++++.+ .++++.+++||++++++|||++|+++|+|++|++ .|+.||++++.+++.|+.++++|+ T Consensus 88 ~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C~ 165 (180) T SUPFAM0016837 88 HTLQVKYGCELNNGG--LVRGFLRYAYNGEDFLRFDSDLGTWVAVTELGVILLLLLTAEKWNSDKDLLEQLRAYLDTTCR 165 (180) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHH T ss_conf 689999999983797--078987666567478999557517973645788999999999840458899999988756999 Q ss_pred CCCCCC Q ss_conf 776412 Q Psfainz_l4 77 HNIGIW 82 (84) Q Consensus 77 hN~gv~ 82 (84) |++... T Consensus 166 ~~~~~~ 171 (180) T SUPFAM0016837 166 HWLKKY 171 (180) T ss_pred HHHHHH T ss_conf 999988 No 57 >1es0_B 65 KD glutamic acid decarboxylase+H-2 class II histocompatibility antigen; class II MHC I-A(G7); 2.60A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 Probab=99.65 E-value=6.4e-16 Score=108.38 Aligned_columns=79 Identities=29% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) |.++.+.+|+| |+|+ +|+++.||+||++++++||||+|+|+|.+++|++.++.|| ++.+++.++.++..|++|+. T Consensus 33 fv~Q~~~~Ce~~~gt~--~v~~~~ryaYDGedfi~FDsd~~~~~a~~~~a~~~~~~w~--~~~le~~~~~~~~~c~~~~~ 108 (221) T 1es0_B 33 FVHQFKGECYFTNGTQ--RIRLVTRYIYNREEYLRFDSDVGEYRAVTELGRHSAEYYN--KQYLERTRAELDTACRHNYE 108 (221) T ss_dssp EEEEEEEEEEEETTTT--EEEEEEEEEETTEEEEEEETTTCSEEESSTTTHHHHHHHH--HHHHHHHHHHHHHTHHHHHH T ss_pred EEEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHH--HHHHHHHHHHCCCCCCCCCC T ss_conf 7999977789817982--5789988776374678883554679708878989888776--66666755301100013431 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) .... T Consensus 109 ~~~~ 112 (221) T 1es0_B 109 ETEV 112 (221) T ss_dssp HTTT T ss_pred CCCC T ss_conf 2311 No 58 >SUPFAM0024649 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d2vaaa2. Probab=99.65 E-value=5.1e-16 Score=108.91 Aligned_columns=78 Identities=31% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+..|.+ +++. .++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+||++ T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~~~ 169 (181) T SUPFAM0024649 93 HTLQVMYGCELTNDGS--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTELAVITAEKWNSD-GLLEQLRAYLEGTCRENLG 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7999988877748970--677887776567478998456417984576789999871653-7899999988768899999 Q ss_pred CC Q ss_conf 12 Q Psfainz_l4 81 IW 82 (84) Q Consensus 81 v~ 82 (84) +. T Consensus 170 ~~ 171 (181) T SUPFAM0024649 170 KY 171 (181) T ss_pred HH T ss_conf 88 No 59 >SUPFAM0017878 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1de4a2. Probab=99.64 E-value=6.4e-16 Score=108.40 Aligned_columns=79 Identities=34% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400377641 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGI 81 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv 81 (84) +..+.+..|..++.+ +++++.+++||++++++|||++|+++|+|++|++.|+.||++++.+++.|+.++++|+||+++ T Consensus 91 ~~~q~~~~c~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~ 168 (178) T SUPFAM0017878 91 HTLQVMYGCELNSDG--RVRGFWRYAYNGEDFLRFDSDLGTWVAVTELAQITAEKWNSDKELLEQLRAYLETYCRHNLGK 168 (178) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHH T ss_conf 589898999875898--079998776657578999556417974668899999971265889999999875488999999 Q ss_pred C Q ss_conf 2 Q Psfainz_l4 82 W 82 (84) Q Consensus 82 ~ 82 (84) + T Consensus 169 ~ 169 (178) T SUPFAM0017878 169 Y 169 (178) T ss_pred H T ss_conf 8 No 60 >SUPFAM0022064 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1lqva_. Probab=99.64 E-value=9.8e-16 Score=107.41 Aligned_columns=76 Identities=30% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCC----CCHHHCCCCHHHHHHHHHHHCCCCC Q ss_conf 30347878886-579962058998887576999998077774870173014----0324506886697767542034003 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGV----KQAEAWNKDQGQLAVWRAQKETYCQ 76 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~----~~Ae~wN~~~~~Le~~Ra~vdt~Cr 76 (84) +..+.+..|++ |++. +++++.+++||++++++|||++|+++|+|++|+ +.|+.||++++.+++.|+.++++|+ T Consensus 87 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C~ 164 (172) T SUPFAM0022064 87 HTLQVKYGCELTNDGS--RVRGFLRYAYNGEDFLRFDSDVGTWVAVTELGVRAKLITAEKWNSDKGLLEQLRAYLETTCR 164 (172) T ss_pred EEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHH T ss_conf 6999999999828981--57899878756757899965651798424456788888998731677799999998865889 Q ss_pred CCC Q ss_conf 776 Q Psfainz_l4 77 HNI 79 (84) Q Consensus 77 hN~ 79 (84) ++. T Consensus 165 ~~l 167 (172) T SUPFAM0022064 165 EWL 167 (172) T ss_pred HHH T ss_conf 999 No 61 >PTHR19944 MHC CLASS II-RELATED. Probab=99.63 E-value=9.1e-20 Score=128.98 Aligned_columns=78 Identities=29% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCC---CHHHHHHHHHHHCC---- Q ss_conf 30347878886-57996205899888757699999807777487017301403245068---86697767542034---- Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNK---DQGQLAVWRAQKET---- 73 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~---~~~~Le~~Ra~vdt---- 73 (84) |+.+.+.+|+| |||+ +|++|.|+++|++++++|+|++|++.+.|++|++.++.||+ +.++|++.||++|+ T Consensus 44 f~~~~~~~C~~~nGt~--~vr~l~r~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~le~~r~~~d~~k~~ 121 (284) T PTHR19944 44 FVYQFKAECYFTNGTE--RVRLLERYIYNREEFVVFDSDVGEVRALTELGRPDAEYWNSALQQKDVLEQKRAEVDTAKAN 121 (284) T ss_pred HHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 9999987465430489--99999999730388999988789999988765678889998898999999999999999999 Q ss_pred ---------CCCCCCCC Q ss_conf ---------00377641 Q Psfainz_l4 74 ---------YCQHNIGI 81 (84) Q Consensus 74 ---------~CrhN~gv 81 (84) +|||||++ T Consensus 122 l~~~~~~~~~Cr~ny~~ 138 (284) T PTHR19944 122 LDILIKRSNVCRHNYEV 138 (284) T ss_pred HHHHHHHHHHHHHHHHH T ss_conf 99999999987877767 No 62 >SUPFAM0021328 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1k2db2. Probab=99.63 E-value=5.9e-16 Score=108.60 Aligned_columns=80 Identities=31% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) .|..+.+..|++ ++++ +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ .+++.|+.++++|++|+ T Consensus 2 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~C~~~~ 77 (87) T SUPFAM0021328 2 SHTLQVMYGCEFLNDTG--RVRGLDQYAYNGEEFLRFDSDVGTWVAVTELAVITAEKWNSD--LLEQLRAYLETYCRENL 77 (87) T ss_pred CEEEEEEEEEEECCCCC--CEEEEEEEEECCEEEEEECCCCCEEEECCHHHHHHHHHHCHH--HHHHHHHHHHHHHHHHH T ss_conf 35888886667717986--123565421077123677065427851308899999862316--89999988877768988 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) +++.+ T Consensus 78 ~~~~~ 82 (87) T SUPFAM0021328 78 KKYLE 82 (87) T ss_pred HHHHH T ss_conf 88775 No 63 >SUPFAM0020064 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1hdmb2. Probab=99.61 E-value=3e-15 Score=104.79 Aligned_columns=80 Identities=29% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+.+|++ ++++ .++++.+++||++++++|||++|+++|+|++|++.|+.||++++.++.. +..++.|+++.+ T Consensus 1 ~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~c~~~~~~ 77 (85) T SUPFAM0020064 1 HTLQVKYGCEFLNDGS--LVRFLDQYAYNGEDFLRFDSDVGKWVAVTELAVITAEKWNSDKALLERR-ALEDTCCEWLKG 77 (85) T ss_pred CEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHH-HHHHHHHHHHHH T ss_conf 9368876568748983--2235665544775789982665368624177887887615866788888-875344777776 Q ss_pred CCCC Q ss_conf 1259 Q Psfainz_l4 81 IWYS 84 (84) Q Consensus 81 v~yS 84 (84) .+.+ T Consensus 78 ~~~~ 81 (85) T SUPFAM0020064 78 YLEY 81 (85) T ss_pred HHHH T ss_conf 7531 No 64 >SUPFAM0018655 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1es0b2. Probab=99.60 E-value=3.2e-15 Score=104.66 Aligned_columns=80 Identities=31% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|++ ++++ .++++.+++||++++++|||++|++++.|++|++.|+.||++ .+++.|+.+++.|++|+ T Consensus 2 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~C~~~~ 77 (87) T SUPFAM0018655 2 GHTLQVMSGCELLNDTG--LVRGFLQYAYNGEDFLRFDSDVGEWVAATELAVITAEKWNSD--LLEQLRAYLETYCRENL 77 (87) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCHH--HHHHHHHHHHHHHHHHH T ss_conf 55889999999817985--246888886568367888177417874567898999872337--89999987754778888 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 78 ~~~~~ 82 (87) T SUPFAM0018655 78 QRYLE 82 (87) T ss_pred HHHHH T ss_conf 87774 No 65 >SUPFAM0020208 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1hsba2. Probab=99.59 E-value=5.1e-15 Score=103.57 Aligned_columns=76 Identities=33% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCC--- Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037--- Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQH--- 77 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~Crh--- 77 (84) +..+.+..|.+ +++. +++++.+++||++++++|||++|+|+|+|++|++.|+.||++ +.+++.|+.++++|+| T Consensus 93 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~w~~~~~~~~~~~~~w~~~-~~~~~~~~~~~~~C~~~l~ 169 (181) T SUPFAM0020208 93 HTLQVKYGCELTNDGS--RVRGFLRYAYNGEDFLRFDSDVGTWVAATELAVITAEKWNSD-GLLEQLRAYLETTCRHWLK 169 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHHHH T ss_conf 7899999999747970--567787676557378998456527984577889999870743-7899999988668999999 Q ss_pred ---CCC Q ss_conf ---764 Q Psfainz_l4 78 ---NIG 80 (84) Q Consensus 78 ---N~g 80 (84) |+| T Consensus 170 ~~~~~~ 175 (181) T SUPFAM0020208 170 KYLNYG 175 (181) T ss_pred HHHHHH T ss_conf 987423 No 66 >SUPFAM0020450 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1iakb2. Probab=99.58 E-value=6.2e-15 Score=103.10 Aligned_columns=80 Identities=30% Q ss_pred CCEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 930347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 1 GFLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 1 gf~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +|..+.+..|.+ +++. +++++.+++||++++++|||++|++++.|++|++.|+.||++ .+++.++.++++|++|+ T Consensus 2 ~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~C~~~~ 77 (87) T SUPFAM0020450 2 GHTLQVKSGCELLNDGS--LVRGFLQYAYNGEDFLRFDSDVGKWVAATELAEITAEKWNSD--LLEQLRAYLETYCRENL 77 (87) T ss_pred CEEEEEEEEEEECCCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHH T ss_conf 45889999999827985--146899987768367888266317974556787888873237--89999988766889988 Q ss_pred CCCCC Q ss_conf 41259 Q Psfainz_l4 80 GIWYS 84 (84) Q Consensus 80 gv~yS 84 (84) ++..+ T Consensus 78 ~~~~~ 82 (87) T SUPFAM0020450 78 RRYLE 82 (87) T ss_pred HHHHH T ss_conf 88874 No 67 >SUPFAM0024675 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d3frua2. Probab=99.53 E-value=3.4e-14 Score=99.15 Aligned_columns=76 Identities=30% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 303478788865799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +..+.+..|.....+ .++++.+++||++++++|||++|+++|+|++|++.|+.||++++++++.|+.++++|+||+ T Consensus 90 ~~~q~~~~C~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~C~~~~ 165 (178) T SUPFAM0024675 90 HTLQVMYGCELDDDG--SVRGFDRYAYNGEDFLRFDSDVGTWVAATELAQITAEKWNSDKDLLEQLRAYLETTCRHNL 165 (178) T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHH T ss_conf 688888887655897--4799876765574789984563079627678999999840548899999998877999999 No 68 >SUPFAM0017311 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1c16a2. Probab=99.34 E-value=5.8e-12 Score=87.24 Aligned_columns=72 Identities=22% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCC Q ss_conf 30347878886-57996205899888757699999807777487017301403245068866977675420340037764 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIG 80 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~g 80 (84) +..+.+..|.+ |++. .++++.+++||++++++|||++|+++|+|++|++.|+.|| +..+..++++|+++.+ T Consensus 90 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~g~~~~~f~~~~~~~~~~~~~~~~~~~~w~------~~~~~~~~~~~~~~~~ 161 (164) T SUPFAM0017311 90 HTLQVKYGCELTNGGE--RVRGFLRYAYNGEDFLRFDSDVGEWVAVTELGRITAEKWN------GECREWLRRYLEYGKE 161 (164) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHC------CHHHHHHHHHHHCCCC T ss_conf 7899999888737970--6889888876574799995565379844745789998742------0689999998740222 Q ss_pred C Q ss_conf 1 Q Psfainz_l4 81 I 81 (84) Q Consensus 81 v 81 (84) + T Consensus 162 ~ 162 (164) T SUPFAM0017311 162 V 162 (164) T ss_pred C T ss_conf 3 No 69 >SUPFAM0023656 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1qo3a2. Probab=99.09 E-value=4.2e-10 Score=77.27 Aligned_columns=75 Identities=24% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCC Q ss_conf 30347878886-5799620589988875769999980777748701730140324506886697767542034003776 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNI 79 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~ 79 (84) +..+.+..|.+ +++. .++...++.||++++++||++++.+++.++.|+..++.||++++ ++..|+.++..|.+++ T Consensus 92 ~~~q~~~~C~~~~~~~--~~~~~~~~~~~g~~~~~~~~~~~~w~~~~~~a~~~~~~~~~~~~-~~~~~~~~~~~C~~~~ 167 (180) T SUPFAM0023656 92 HTLQVMYGCELLNDGS--RVRGFEQYAYDGEDFLSFDSDLGTWTAVTELAQITKEKWNSDKD-LEQLRAYLEGTCVEWL 167 (180) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHCCHH-HHHHHHHHHHHHHHHH T ss_conf 6888888765538972--78888777645715799825641798625667999998504436-8999998877889999 No 70 >SUPFAM0018479 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1efxa2. Probab=99.02 E-value=1.8e-09 Score=73.86 Aligned_columns=72 Identities=24% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCC Q ss_conf 30347878886-5799620589988875769999980777748701730140324506886697767542034003 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQ 76 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~Cr 76 (84) +..+.+..|.+ +++. .++...++.||++++++||++++.+++.+++|++.++.||++++ ++..|+.+++.|+ T Consensus 93 ~~~Q~~~~C~~~~~~~--~~~~~~~~~~~g~~~~~~~~~~~~w~~~~~~a~~~~~~w~~~~~-~~~~~~~~~~~C~ 165 (181) T SUPFAM0018479 93 HTLQVMYGCELLNDGS--RVRGFLQYAYDGEDFLSFDSDLGTWTAATPLAQITKEKWNSDKD-LEQLRAYLEGTCV 165 (181) T ss_pred EEEEEEEEEEECCCCE--EEEEEEEEEECCCEEEEEECCCCEEEECCHHHHHHHHHHCCCHH-HHHHHHHHHHHHH T ss_conf 6888888887648963--77778777655714789835651798645667999998404347-8999999878899 No 71 >3fru_A Neonatal FC receptor; HET: NAG FUC MAN GAL; 2.2A {Rattus norvegicus} SCOP: b.1.1.2 d.19.1.1 PDB: 1frt_A* 1i1a_A* Probab=98.83 E-value=3.3e-08 Score=67.13 Aligned_columns=75 Identities=13% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400377 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHN 78 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN 78 (84) +..+.+.-|-.+... ..+...++.||+++++.||++.++++|.++.++..++.||++++.+++.|+..+..|.++ T Consensus 90 htlQ~~~GCEl~~dg--~~~~~~q~~YDGedfl~fD~~t~~wva~~~~a~~~~~~w~~~~~~~~~~k~yle~~C~~~ 164 (269) T 3fru_A 90 FTLQGLLGCELAPDN--SSLPTAVFALNGEEFMRFNPRTGNWSGEWPETDIVGNLWMKQPEAARKESEFLLTSCPER 164 (269) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHTSSHHHHHHHHHHHHTHHHHH T ss_pred EEEEEEEEEEECCCC--CEEEEEEEEECCEEEEEEECCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 068999999974698--155579997768044455256566970872688898875311888999999874134554 No 72 >1s7q_A H-2KB, H-2 class I histocompatibility antigen, K-B alpha chain; 1.99A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 PDB: 1s7r_A 1s7s_A 1s7t_A 1bii_A 1s7u_A 1s7v_A 1s7w_A 1s7x_A 1nez_A* Probab=98.65 E-value=1.9e-07 Score=63.06 Aligned_columns=73 Identities=18% Q ss_pred C-CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCC Q ss_conf 9-30347878886-5799620589988875769999980777748701730140324506886697767542034003 Q Psfainz_l4 1 G-FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQ 76 (84) Q Consensus 1 g-f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~Cr 76 (84) | +..+.+..|.+ +.+. .+++..+|.||+++++.||++.+.++|.++.++..++.||+++ .+++.|+.++..|. T Consensus 91 g~htlQ~~~GCEl~~dg~--~~~g~~~~ayDGeDfi~fD~d~~~w~a~~~~a~~~k~kwe~~~-~~~~~k~~l~~~C~ 165 (348) T 1s7q_A 91 GSHTIQVISGCEVGSDGR--LLRGYQQYAYDGCDYIALNEDLKTWTAADMAALITKHKWEQAG-EAERLRAYLEGTCV 165 (348) T ss_dssp SCCEEEEEEEEEECTTSC--EEEEEEEEEETTEEEEEECTTSSCEEESSHHHHHHHHHHHHTT-HHHHHHHHHHTHHH T ss_pred CCEEEEEEEEEEECCCCC--EEEEEEEEEECCCEEEEEECCCCEEECCCHHHHHHHHHHHHCC-HHHHHHHHHHHHHH T ss_conf 737999988764458880--5788899887282356870776679728768999999852033-47899999863106 No 73 >1exu_A IGG receptor FCRN large subunit P51; immunoglobulin binding protein; 2.7A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 Probab=98.55 E-value=3.6e-07 Score=61.62 Aligned_columns=77 Identities=10% Q ss_pred EEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCCC Q ss_conf 3478788865799620589988875769999980777748701730140324506886697767542034003776412 Q Psfainz_l4 4 EYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGIW 82 (84) Q Consensus 4 ~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv~ 82 (84) .+.+.-|..+... ..+-..++.||++.++.||++.+.++|.++.++..++.||+++..++..|+.++..|.++...+ T Consensus 90 lQ~~~GCel~~dg--~~~g~~~~aydG~d~l~fD~~~~~w~~~~~~a~~~~~kw~~~~~~~~~~k~yle~~C~~~L~ky 166 (267) T 1exu_A 90 LQGLLGCELGPDN--TSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSCPHRLREH 166 (267) T ss_dssp EEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHHTSTTHHHHHHHHHHTHHHHHHHHH T ss_pred EEEEEEEEECCCC--CCCCEEEEEEECEEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 9887751034763--1122268887060789973775535058879999998755688999999999877889999998 No 74 >1mhc_A MHC class I antigen H2-M3; HET: NAG; 2.1A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 Probab=98.51 E-value=5.3e-07 Score=60.70 Aligned_columns=71 Identities=14% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886-579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +..+.+..|.. +.+. .++...++.||+++|+.||++.+.++|.++.|.+.++.||+++. +++.++.++..| T Consensus 93 htlQ~~~gCel~~d~~--~~~~~~~~~ydG~dfl~fD~d~~~w~~~~~~a~~~k~kw~~~~~-~~~~k~~l~~~C 164 (282) T 1mhc_A 93 HILQWMVSCEVGPDMR--LLGAHYQAAYDGSDYITLNEDLSSWTAVDMVSQITKSRLESAGT-AEYFRAYVEGEC 164 (282) T ss_dssp CEEEEEEEEEECTTSC--EEEEEEEEEETTEEEEEECTTSSCEEECSHHHHHHHHHHHHHCT-HHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCCC--CCCEEEEEEECCCEEEEEECCCCEEEECCHHHHHHHHHHCCHHH-HHHHHHHHHHHH T ss_conf 6999998999756884--22226887417820488815667797088589999987301016-899999874112 No 75 >1t7v_A Zinc-alpha-2-glycoprotein; HET: NAG P6G; 1.95A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1t7w_A* 1t7x_A* 1t7y_A* 1t7z_A* 1t80_A* 1zag_A* Probab=98.49 E-value=9.7e-07 Score=59.31 Aligned_columns=75 Identities=15% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400377 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHN 78 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN 78 (84) +..+.+.-|.....+ -+.-..++.||+++++.||++.+.+++.++.+++.++.||+++..+++.++..+..|.++ T Consensus 95 hvlQ~~~GCEl~~~~--~~~g~~~~aydG~d~i~fD~~~~~w~~~~~~a~~~~~~w~~~~~~~~~~k~yl~~~C~~~ 169 (278) T 1t7v_A 95 HVLQGRFGCEIENNR--SSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEECPAT 169 (278) T ss_dssp CEEEEEEEEEEETTE--EEEEEEEEEETTEEEEEEETTTTEEEECSHHHHHHHHHHTSSTHHHHHHHHHHHTHHHHH T ss_pred EEEEEEEEEECCCCC--EEEEEEEEEECCCHHHHHHCCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 589999986037884--100277788738003112136754983668999999986203889999988766766666 No 76 >1k5n_A Major histocompatibility complex molecule HLA- B*2709; MHC(major histocompatibility complex), HLA(human leukocyte antigen); 1.09A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1jgd_A 1of2_A 1uxw_A 1w0w_A 2bss_A 2bsr_A 2a83_A 1jge_A 1hsa_A 1uxs_A 1w0v_A 1ogt_A 2bst_A 1n2r_A 1sys_A 1syv_A 2bvp_A 2bvo_A 2bvq_A 1m6o_A 1m05_A 1mi5_A 1a1o_A 1agd_A 1agb_A 1agc_A 1age_A 1agf_A 1a1m_A 1a9e_A 1a9b_A 1xh3_A 1zhk_A 1zsd_A 2axg_A 2cik_A 2fyy_A 2h6p_A 2nx5_A 1e27_A 1cg9_A 2hjl_A 2hjk_A 1a1n_A 1e28_A 1zhl_A 2ak4_A 2axf_A 2fz3_A 2nw3_A 1xr9_A 1xr8_A 2bck_A 1efx_A 1x7q_A 1q94_A 1qvo_A 2hn7_A* 1zvs_A 1w72_A 1im9_A 1oga_A 1akj_A 1p7q_A 2bnq_A 2bnr_A 2bsu_A 2bsv_A 2c7u_A 1qqd_A 2av7_A 1i4f_A* 1ao7_A 1b0r_A 1bd2_A 1b0g_A 1duy_A 1eey_A 1eez_A 1hhg_A 1hhh_A 1hhi_A 1hhj_A 1hhk_D 1i1f_A 1i1y_A 1duz_A* 1i7r_A 1i7t_A 1i7u_A 1im3_A 1jf1_A 1jht_A 1lp9_A 1qew_A 1qr1_A 1s8d_A 1t1w_A 1t1x_A 1t1y_A 1t1z_A 1t20_A 1t21_A 1t22_A 1tvb_A 1tvh_A 2clr_A 2f53_A 2git_A 2gj6_A* 2av1_A 1s9w_A 1qse_A 1qrn_A 1s9x_A 1s9y_A 2f54_A 1qsf_A 2dyp_A 2d31_A 1hsb_A 2hla_A 3hla_A 1hla_A 1ydp_A 1hhk_A 1kpr_A 1ktl_A 2esv_A 1mhe_A 1kjm_A 1ed3_A 1t0n_A 2clv_A 2clz_A 2ol3_H* 1rjy_A 1rjz_A 2fwo_A 1ldp_H* 1vgk_A 1k8d_A 1n59_A 1kj3_H 1kj2_H* 1t0m_A 1nan_H 1fo0_H 1wbz_A 1nam_H 1wbx_A 1n5a_A* 1qlf_A 1wby_A 1zhb_A 2f74_A 1jpf_A 1fg2_A 1jpg_A 1lk2_A* 1g6r_H 1bqh_A* 1g7q_A* 1kbg_H* 1kpu_A* 1kpv_A* 1g7p_A* 1osz_A 1p1z_A 1p4l_A 1rk0_A* 1rk1_A* 1vac_A 1vad_A 2ckb_H 2fo4_A* 2vaa_A 2vab_A 1qo3_A 1n3n_A 1fzm_A* 1fzo_A* 1inq_A 1ld9_A 1juf_A 1mwa_H* 1ddh_A 1ce6_A 1leg_A* 2cii_A 1zt1_A 1yn6_A 1ffn_A 1ffo_A 1ffp_A 1yn7_A 1fzk_A* 1fzj_A* 1bz9_A 1lek_A* 1kjv_A 1zt7_A 2mha_A 1hoc_A 1tmc_A 2e7l_E 2oi9_A Probab=98.29 E-value=6.3e-06 Score=54.98 Aligned_columns=71 Identities=15% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886-579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +..+.+..|.+ +.+. -++...++.||+++++.||++.+.+++.++.+...++.||+++ .+...++..+..| T Consensus 93 h~lQ~~~gCe~~~~~~--~~~g~~q~~yDG~d~i~fD~~~~~wv~~~~~a~~~k~~w~~~~-~~~~~~~~~~~~c 164 (276) T 1k5n_A 93 HTLQNMYGCDVGPDGR--LLRGYHQHAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAR-VAEQLRAYLEGEC 164 (276) T ss_dssp CEEEEEEEEEECTTCC--EEEEEEEEEETTEEEEEECTTSSCEEESSHHHHHHHHHHHHTT-HHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCCC--EEEEEEEEEECCCEEEEECCCCEEEECCCHHHHHHHHHHHHHH-HHHHHHHHHHCCC T ss_conf 5999999887638875--2455456531472134543860089808858999998763101-5788875431020 No 77 >1a6z_A HFE; 2.6A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1de4_A* Probab=98.28 E-value=1.2e-05 Score=53.46 Aligned_columns=72 Identities=17% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +-.+.+..|...... .++...++.||++.++.||++.+.+++.++.++..++.|++++..++..|+-.+..| T Consensus 94 HtlQ~~~GCEl~~dg--~~~g~~~~~ydG~d~l~fd~~~~~w~~~~~~a~~~~~kw~~~~~~~~~~k~~le~~C 165 (275) T 1a6z_A 94 HTLQVILGCEMQEDN--STEGYWKYGYDGQDHLEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDC 165 (275) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEEGGGTEEEESSGGGHHHHHHHHSSTHHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--EEEEEEEEEECCEEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHCCCC T ss_conf 267677775235687--577899886578289999778036971876899999987433788998877631575 No 78 >1zs8_A Histocompatibility 2, M region locus 10.5; HET: NAG; 3.00A {Mus musculus} Probab=98.09 E-value=1.2e-05 Score=53.46 Aligned_columns=69 Identities=14% Q ss_pred EEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886-579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+..|.+ +.+. .++...++.||+++|+.||++.+.+++.++.+.+.++.||.+ ...+..|+..+..| T Consensus 94 lQ~~~gCe~~~dg~--~~~~~~~~~ydG~Dfl~fd~~~~twta~~~~a~~~~~~w~~~-~~~~~~k~~l~~~C 163 (274) T 1zs8_A 94 LQEVFGCNVAHDGS--FLGGHYGLTYYGYDYIILNEDLNSWTTEGKVGGKFNPDRTQG-SVTEGWRTYLKGEC 163 (274) T ss_dssp EEEEEEEEECTTSC--EEEEEEEEEETTTEEEECCTTSSCCCCCSHHHHTCC-------CHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCCC--EEEEEEEECCCCEEEEEECCCCCEEECCCHHHHHHHHHHHHH-HHHHHHHHHHCCHH T ss_conf 98898899878984--610143311355001243055565860407778888777789-99999998732000 No 79 >d1a6za2 d.19.1.1 (A:4-181) Hemochromatosis protein Hfe, alpha-1 and alpha-2 domains {Human (Homo sapiens)} Probab=96.94 E-value=0.017 Score=36.67 Aligned_columns=72 Identities=17% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-.... .++-...+-||.+.|+.||.+...+++.++-++...+.||+++..++..|.-.+.-| T Consensus 91 htlQ~~~gCE~~~dg--~~~g~~~~aydG~dfl~fd~~~~~W~~~~~~A~~tk~kW~~~~~~~e~~k~yl~~~C 162 (178) T d1a6za2 91 HTLQVILGCEMQEDN--STEGYWKYGYDGQDHLEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDC 162 (178) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEEGGGTEEEESSGGGHHHHHHHHSSTHHHHHHHHHHHTHH T ss_pred EEEEEEEEEECCCCC--EEEEEEEECCCCCCEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHCCHH T ss_conf 068898863017884--022367403488300254367645852876899999998643889999887640302 No 80 >1onq_A T-cell surface glycoprotein CD1A; protein-glycolipid complex, beta sheet platform,; HET: NAG FUC SLF; 2.15A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1xz0_A* Probab=96.58 E-value=0.016 Score=36.69 Aligned_columns=72 Identities=14% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCC-CEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 303478788865799620589988875769999980777-74870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSL-GKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdv-Gkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +..+.+.-|..+..+ -++-..++-||+++|+.||.+. -..++..+.+...++.||.++...+..++..+..| T Consensus 94 h~lQ~~~GCEl~~~~--~~~gf~~~ayDGedfisfd~~t~~~~~~~~~~a~~~~~~~~~~~~~~~~~k~yLe~~C 166 (283) T 1onq_A 94 FEIQVTGGCELHSGK--VSGSFLQLAYQGSDFVSFQNNSWLPYPVAGNMAKHFCKVLNQNQHENDITHNLLSDTC 166 (283) T ss_dssp EEEEEEEEEEEETTE--EEEEEEEEEETTEEEEEEETTEEEECGGGCHHHHHHHHHHTTCHHHHHHHHHHHHTHH T ss_pred EEEEEEECCEECCCC--EEEEEEEEEECCCEEEEEECCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 899984212126994--0345799875385257771671078415248899999875467999999999986445 No 81 >SUPFAM0017311 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1c16a2. Probab=96.56 E-value=0.035 Score=34.92 Aligned_columns=69 Identities=17% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHH Q ss_conf 930347878886579962058998887576999998077774870173014032450688669776754 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRA 69 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra 69 (84) |........|..+...+..++++...+.|+.++++|||+.....+....+...++.|+..+..+..... T Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 69 (164) T SUPFAM0017311 1 GSHSLRYFLTAVSRPGLGLPEFIAVGYVDDVQFLRYDSDRAEPRGPWMKGVESPEYWERETELLKGLLQ 69 (164) T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEECCEEEEEECCCEEEEEEHHHHCCCCHHHHHHHHHHHHHHHH T ss_conf 914898988888606888338999998878889977384258740223113470245557888999999 No 82 >d1t7va2 d.19.1.1 (A:5-183) Zinc-alpha-2-glycoprotein, ZAG {Human (Homo sapiens)} Probab=96.47 E-value=0.044 Score=34.42 Aligned_columns=72 Identities=15% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-+... -++-..++-||.+.|+.||.+...+++.++-++...+.||+++..++..|.-.+.-| T Consensus 91 HtlQ~~~GCE~~~dg--~~~g~~~~~ydG~Dfl~fd~~~~tW~~~~~~A~~tk~~W~~~~~~~e~~k~yl~~~C 162 (179) T d1t7va2 91 HVLQGRFGCEIENNR--SSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEEC 162 (179) T ss_dssp CEEEEEEEEEEETTE--EEEEEEEEEETTEEEEEEETTTTEEEECSHHHHHHHHHHTSSTHHHHHHHHHHHTHH T ss_pred CEEEEEEEEECCCCC--CCCCEEEECCCCCEEEEEECCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHCCC T ss_conf 137777763108996--104555511268300244367765850678999999998767899999998761421 No 83 >d3frua2 d.19.1.1 (A:1-178) Fc (IgG) receptor, alpha-1 and alpha-2 domains {Rat (Rattus norvegicus)} SCOP: d1i1aa2 Probab=96.37 E-value=0.076 Score=33.16 Aligned_columns=72 Identities=14% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-+... -++=..++-||.+.++.||.+...+++.++-+......||.+++.++..|.-.+.-| T Consensus 90 HtlQ~~~GCe~~~d~--~~~g~~q~~ydG~D~l~~d~~~~tW~~~~~~A~~tk~kWe~~~~~~e~~k~yL~~~C 161 (178) T d3frua2 90 FTLQGLLGCELAPDN--SSLPTAVFALNGEEFMRFNPRTGNWSGEWPETDIVGNLWMKQPEAARKESEFLLTSC 161 (178) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHTSSHHHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--CEEEEEEECCCCCCEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHCCCH T ss_conf 478988864234787--312146605687302678357766870786899999998631999999987640510 No 84 >d1t7va2 d.19.1.1 (A:5-183) Zinc-alpha-2-glycoprotein, ZAG {Human (Homo sapiens)} SCOP: d1zaga2 d1zagc2 Probab=96.30 E-value=0.063 Score=33.59 Aligned_columns=72 Identities=15% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-.... -++-...+-||.+.++.||.+...+++.++-+....+.||+++..++..|.-.+.-| T Consensus 91 htlQ~~~GCE~~~~~--~~~g~~~~~ydG~D~l~fd~~~~~W~~~~~~A~~tk~~W~~~~~~~~~~k~yl~~~C 162 (179) T d1t7va2 91 HVLQGRFGCEIENNR--SSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEEC 162 (179) T ss_dssp CEEEEEEEEEEETTE--EEEEEEEEEETTEEEEEEETTTTEEEECSHHHHHHHHHHTSSTHHHHHHHHHHHTHH T ss_pred CEEEEEEEEECCCCC--CCCCEEEECCCCCCEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHHCCH T ss_conf 258999875228995--113244420268410466367776860777899999998877999999987750300 No 85 >1je6_A MICB, MHC class I chain-related protein; delta-TCR, glycoprotein, signa immunoglobulin fold, T-cell, immune system; 2.50A {Homo sapiens} SCOP: b.1.1.2 d.19.1.1 PDB: 1hyr_C 1b3j_A* Probab=96.27 E-value=0.021 Score=36.14 Aligned_columns=72 Identities=8% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCC-----CCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 303478788865799620589988875769999980777748701730-----14032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEV-----GVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~Tel-----G~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +..+.+..|.+.... .++-..++.||+++++.||++.+.+++.+.. +....+.|+.+....+..++.....| T Consensus 89 H~lQ~~~GCel~~d~--s~~~~~~~~ydG~d~i~fD~~~~~w~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (275) T 1je6_A 89 HSLQEIRVCEIHEDS--STRGSRHFYYNGELFLSQNLETQESTVPQSSRAQTLAMNVTNFWKEDAMKTKTHYRAMQADC 165 (275) T ss_dssp EEEEEEEEEEECSSS--CEEEEEEEEETTEEEEEEETTTTEEECCSCHHHHHHHHHHHHHHHTTCSSCSSTTHHHHHHH T ss_pred EEEEEEEEEEECCCC--CCEEEEEEECCCCEEEEECCCCCEEEECCCHHCCHHHHHHHHHHHHHHHHHHHHHHHHHCCC T ss_conf 478899988884554--65038986337722477506444898558500027999998620024899999987632010 No 86 >d1de4a2 d.19.1.1 (A:4-181) Hemochromatosis protein Hfe, alpha-1 and alpha-2 domains {Human (Homo sapiens)} Probab=96.12 E-value=0.059 Score=33.74 Aligned_columns=70 Identities=17% Q ss_pred EEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.-+... .++-...+-||.+.++.||.+...+++.++..+...+.||+++...+..|+-.+.-| T Consensus 93 lQ~~~gCe~~~d~--~~~g~~~~~ydG~d~l~fd~~~~~W~~~~~~A~~~~~~W~~~~~~~~~~k~~l~~~C 162 (178) T d1de4a2 93 LQVILGCEMQEDN--STEGYWKYGYDGQDHLEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDC 162 (178) T ss_dssp EEEEEEEEECTTC--CEEEEEEEEETTEEEEEEEGGGTEEEESSGGGHHHHHHHHHHCHHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCC--EECEEEEECCCCCEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHHCCH T ss_conf 9988876327885--001057622488200133166666822873899999998754889999987650300 No 87 >d3frua2 d.19.1.1 (A:1-178) Fc (IgG) receptor, alpha-1 and alpha-2 domains {Rat (Rattus norvegicus)} Probab=96.06 E-value=0.14 Score=31.79 Aligned_columns=72 Identities=14% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-+... -++=..++-||.+.|+.||.+....++.++.+......|+++++.++..|.-.+.-| T Consensus 90 HtlQ~~~GCE~~~dg--~~~g~~q~~yDG~Dflsfd~~~~~W~~~~~~A~~tk~kW~~~~~~~e~~k~yL~~~C 161 (178) T d3frua2 90 FTLQGLLGCELAPDN--SSLPTAVFALNGEEFMRFNPRTGNWSGEWPETDIVGNLWMKQPEAARKESEFLLTSC 161 (178) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHTSSHHHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--CEEEEEEECCCCCEEEEEECCCCEECCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCC T ss_conf 589999877655788--333246516787123578547662227887999999988756999999987640520 No 88 >d1kcgc_ d.19.1.1 (C:) Class I MHC-related molecule Ulbp3 {Human (Homo sapiens)} Probab=96.02 E-value=0.066 Score=33.45 Aligned_columns=70 Identities=17% Q ss_pred EEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.-+... -++-..++-||.+.|+.||.+...+++.++-+....+.|++++...+..++-.+.-| T Consensus 93 lQ~~~GCel~~dg--~~~g~~~~~ydG~dfl~fd~~~~~W~~~~~~A~~~k~~w~~~~~~~~~~k~yL~~~C 162 (178) T d1kcgc_ 93 LQVRMSCECEADG--YIRGSWQFSFDGRKFLLFDSNNRKWTVVHAGARRMKEKWEKDSGLTTFFKMVSMRDC 162 (178) T ss_dssp EEEEEEEEECSSC--CCEEEEEEESSSSEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCC--CCCCEEEECCCCCEEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHHCHH T ss_conf 9999877516787--544406640368403476557762424870799999998877999999987640403 No 89 >d1kjva2 d.19.1.1 (A:1-181) Class I MHC, alpha-1 and alpha-2 domains {Rat (Rattus norvegicus), RT1-AA} Probab=96.01 E-value=0.076 Score=33.14 Aligned_columns=71 Identities=15% Q ss_pred CEEEEEEEEEE-CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886-579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVF-TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~F-n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.. +.+. .++....+-||.+.++.||.+.+.+++.++-+....+.||.++. ++..|+-.+.-| T Consensus 93 htlQ~~~gCe~~~dg~--~~~g~~~~~ydG~d~l~ld~~~~~w~~~~~~a~~~~~~w~~~~~-~~~~k~yl~~~C 164 (181) T d1kjva2 93 HTIQEMYGCDVGSDGS--LLRGYEQFAYDGRDYIALNEDLKTWTAADFAARISRNKLERDGF-ADLHRAYLEGEC 164 (181) T ss_dssp CEEEEEEEEEECTTSC--EEEEEEEEEETTEEEEEECTTSSCEEECSHHHHHHHHHHHHTTH-HHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCCC--EECCEEEECCCCCCEEEEECCCCEEECCCHHHHHHHHHHHHHHH-HHHHHHHHCCCC T ss_conf 1899997534547885--52122552237841036626776685078899999987201678-999876540423 No 90 >d1exua2 d.19.1.1 (A:4-176) Fc (IgG) receptor, alpha-1 and alpha-2 domains {Human (Homo sapiens)} Probab=95.97 E-value=0.11 Score=32.18 Aligned_columns=72 Identities=10% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-.... .++-..++-||.+.|+.||.+....++...-+...++.||+++...+..|.-.+.-| T Consensus 85 HtlQ~~~GCEl~~dg--~~~~~~~~~ydG~Dfl~fd~~~~~w~~~~~~a~~~~~kw~~~~~~~~~~k~yl~~~C 156 (173) T d1exua2 85 YTLQGLLGCELGPDN--TSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSC 156 (173) T ss_dssp CEEEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHHTSTTHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--CCCCEEEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCC T ss_conf 678744567765788--310202111368651575457674347876899999988867899999997650643 No 91 >d1exua2 d.19.1.1 (A:4-176) Fc (IgG) receptor, alpha-1 and alpha-2 domains {Human (Homo sapiens)} Probab=95.83 E-value=0.13 Score=31.88 Aligned_columns=70 Identities=10% Q ss_pred EEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.-...+ .++=...+-||.+.++.||.+....++.++-+....+.||++...++..|.-.+.-| T Consensus 87 lQ~~~GCe~~~dg--~~~g~~~~aydG~D~l~~d~~~~tw~~~~~~A~~~~~~w~~~~~~~~~~k~yl~~~C 156 (173) T d1exua2 87 LQGLLGCELGPDN--TSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSC 156 (173) T ss_dssp EEEEEEEEECTTS--CEEEEEEEEETTEEEEEEETTTTEEECSSHHHHHHHHHHHTSTTHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCC--CCCCEEEEEECCCCEEEEECCCCEEECCCHHHHHHHHHHHHHHHHHHHHHHHHCCCC T ss_conf 7756777873566--413525654458640476567654743877899999998766899999997641530 No 92 >1zt4_A T-cell surface glycoprotein CD1D; HET: AGH; 3.00A {Homo sapiens} Probab=95.74 E-value=0.14 Score=31.66 Aligned_columns=73 Identities=10% Q ss_pred CCEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCH-HHCCCCHHHHHHHHHHHCCCC Q ss_conf 930347878886579962058998887576999998077774870173014032-450688669776754203400 Q Psfainz_l4 1 GFLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQA-EAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 1 gf~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~A-e~wN~~~~~Le~~Ra~vdt~C 75 (84) ++..+.+.-|...... -.+-..++.||++.|+.||.+...+++.++.....+ +.||.++...+..|+-.+.-| T Consensus 93 ~htlQ~~~GCEl~~dg--~~~gf~q~ayDG~Dflsfd~~t~~~~~~~~~~~~~~~~~~~~~~~~~e~~k~yLe~~C 166 (281) T 1zt4_A 93 PLELQVSAGCEVHPGN--ASNNFFHVAFQGKDILSFQGTSWEPTQEAPLWVNLAIQVLNQDKWTRETVQWLLNGTC 166 (281) T ss_dssp SEEEEEEEEEEECSSS--CEEEEEEEEETTEEEEEEETTEEEECSSCCTHHHHHHHHHTTCTTHHHHHHHHHHTHH T ss_pred CEEEEEEEEEEECCCC--CEEEEEEEEECCEEEEEEECCCCEECHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCC T ss_conf 7799988764876998--2200578987681699993673426301478999999984101678899998750400 No 93 >1cd1_A CD1, MCD1D.1; 2.67A {Mus musculus} SCOP: b.1.1.2 d.19.1.1 Probab=95.72 E-value=0.18 Score=31.15 Aligned_columns=72 Identities=15% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCC-CCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173-014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNE-VGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~Te-lG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +..+.+.-|...... -++-..++-||.+.++.||.+....++-.. ......+.||.+++..+..++-.+.-| T Consensus 93 htlQ~~~GCEl~~dg--~~~gf~q~ayDG~dfl~fd~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~k~yL~~~C 165 (315) T 1cd1_A 93 IEIQLSAGCEMYPGN--ASESFLHVAFQGKYVVRFWGTSWQTVPGAPSWLDLPIKVLNADQGTSATVQMLLNDTC 165 (315) T ss_dssp EEEEEEEEEEECSSS--CEEEEEEEEETTEEEEEEETTEEEECTTCCGGGHHHHHHHTTCHHHHHHHHHHHHTHH T ss_pred EEEEEEECCEECCCC--CCCCEEEEEECCEEEEEEECCCEEECCCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC T ss_conf 899875322226987--4310555664570668880783057334136899999986335889999999870572 No 94 >d1k5na2 d.19.1.1 (A:1-181) Class I MHC, alpha-1 and alpha-2 domains {Human (Homo sapiens), HLA-B27} SCOP: u2a83a2 d1n2ra2 d1syva2 d1m6oa2 d1a1oa2 d1m05a2 d1e27a2 d1xh3a2 d1e28a2 d1cg9a2 d1a1na2 d1efxa2 u1x7qa2 d1im9a2 d1hsba2 d1qqda2 d1i4fa2 d1w72a2 d1tmca_ d1ld9a2 d1fzoa2 d1kjma2 d1kpra2 d1kj3h2 d1lk2a2 d1fzka2 d1p4la2 d1p1za2 d1leka2 d1biia2 d1k8da2 u2esva2 d1qo3a2 d1ddha2 d1jufa2 u1wbxa2 Probab=95.68 E-value=0.12 Score=32.11 Aligned_columns=69 Identities=16% Q ss_pred EEEEEEEEECCCCCCC-EEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 3478788865799620-58998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVFTSPDLKD-IEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~Fn~tel~d-v~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.-..-. . ++-...+-||.+.|+.||.+...+++.++.+....+.|+.++. .++.|+-.+.-| T Consensus 95 lQ~~~GCe~~~dg--~~~~g~~~~~ydG~dfl~~d~~~~~W~~~~~~A~~~k~kWe~~~~-~~~~k~yL~~~C 164 (181) T d1k5na2 95 LQNMYGCDVGPDG--RLLRGYHQHAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARV-AEQLRAYLEGEC 164 (181) T ss_dssp EEEEEEEEECTTC--CEEEEEEEEEETTEEEEEECTTSSCEEESSHHHHHHHHHHHHTTH-HHHHHHHHHTHH T ss_pred EEEEEEEEECCCC--CCCCCEEEECCCCCCCEEEECCCCEEECCCHHHHHHHHHHHHHHH-HHHHHHHHCCCC T ss_conf 9988762245888--241432442347830002307776683277799999998611247-788875440544 No 95 >1kcg_C ULBP3 protein; protein-protein complex, C-type lectin-like receptor, MHC class I-like molecule; HET: GSH; 2.60A {Homo sapiens} SCOP: d.19.1.1 Probab=95.51 E-value=0.16 Score=31.48 Aligned_columns=72 Identities=17% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) +-.+.+.-|...... -++-...+-||.+.++.||.+.+..++..+-++.....|+.++...+..++-.+.-| T Consensus 91 htlQ~~~GCel~~dg--~~~g~~~~~ydG~dfl~fd~~~~~W~~~~~~a~~~k~kw~~~~~~~~~~k~~l~~~C 162 (178) T 1kcg_C 91 LTLQVRMSCECEADG--YIRGSWQFSFDGRKFLLFDSNNRKWTVVHAGARRMKEKWEKDSGLTTFFKMVSMRDC 162 (178) T ss_dssp CEEEEEEEEEECSSC--CCEEEEEEESSSSEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--CCCEEEEEECCCCEEEEEECCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHHHH T ss_conf 689988877523787--211158872168514687768767984487899999998530889999998763124 No 96 >d1neza2 d.19.1.1 (A:1-181) Class I MHC, alpha-1 and alpha-2 domains {Mouse (Mus musculus), tla(c), H-2 class} Probab=95.40 E-value=0.16 Score=31.39 Aligned_columns=68 Identities=18% Q ss_pred EEEEEEEEE--CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886--579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVF--TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~F--n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.- +++ -++...++-||.+.|+.||.+...+++.++-++...+.|+ +...+++.|+-.+.-| T Consensus 95 lQ~~~GCel~~dg~---~~~g~~q~ayDG~D~i~ld~~~~tWta~~~~A~~~k~kWe-~~~~~~~~k~yL~~~C 164 (181) T d1neza2 95 IQVMYGCEVEFFGS---LFRAYEQHGYDGQDYIALNEDLKTWTAADMAAEITRSKWE-QAGYTELRRTYLEGPC 164 (181) T ss_dssp EEEEEEEEEETTTT---EEEEEEEEEETTEEEEEECTTSSCEEESSHHHHHHHHHHH-HHTHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCCC---EECCEEECCCCCCCCEEEECCCCEEEECCHHHHHHHHHHC-HHHHHHHHHHHHCCCC T ss_conf 99988741126774---3044042130882101341678668606778988887513-1678989864331523 No 97 >SUPFAM0021061 d.19.1 MHC antigen-recognition domain (54452) SCOP seed sequence: d1jk8a2. Probab=95.38 E-value=0.049 Score=34.18 Aligned_columns=54 Identities=17% Q ss_pred EEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCCCCCCCC Q ss_conf 8998887576999998077774870173014032450688669776754203400377641 Q Psfainz_l4 21 EYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYCQHNIGI 81 (84) Q Consensus 21 ~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~CrhN~gv 81 (84) ++...+.||.+++++|||+..+.++.++.. ++.|+.++......... |++|+.+ T Consensus 19 ~~~~~~~~Dg~~~~~~D~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~l~~ 72 (84) T SUPFAM0021061 19 EGVAVGGYDGEEFLYFDSDTKRWVPRLPWA---ADYWEWETQIALGNIQL----CKENLET 72 (84) T ss_pred CEEEEEEECCEEEEEEECCCCEEEECCHHH---HHHHHCCHHHHHHHHHH----HHHHHHH T ss_conf 646998766826778635763577724123---02441145788999999----9999999 No 98 >d1kcgc_ d.19.1.1 (C:) Class I MHC-related molecule Ulbp3 {Human (Homo sapiens)} Probab=95.36 E-value=0.19 Score=31.06 Aligned_columns=72 Identities=17% Q ss_pred CEEEEEEEEEECCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVFTSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~Fn~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.-+... -++-...+-||.+.++.||.+.+.+++.+.-+....+.|++++...+..++-.+.-| T Consensus 91 htlQ~~~GCel~~d~--~~~g~~~~~ydG~dfl~fd~~~~~W~~~~~~a~~~k~~w~~~~~~~~~~k~~l~~~C 162 (178) T d1kcgc_ 91 LTLQVRMSCECEADG--YIRGSWQFSFDGRKFLLFDSNNRKWTVVHAGARRMKEKWEKDSGLTTFFKMVSMRDC 162 (178) T ss_dssp CEEEEEEEEEECSSC--CCEEEEEEESSSSEEEEEETTTTEEEESSGGGHHHHHHHHHCHHHHHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCC--CCEEEEEEECCCCEEEEEECCCCEEEECCHHHHHHHHHHHHHHHHHHHHHHHHHCHH T ss_conf 799988876406787--300157761378413578767667982487899999998644899999998752214 No 99 >d1kjva2 d.19.1.1 (A:1-181) Class I MHC, alpha-1 and alpha-2 domains {Rat (Rattus norvegicus), RT1-AA} Probab=95.12 E-value=0.25 Score=30.42 Aligned_columns=70 Identities=16% Q ss_pred CEEEEEEEEEE--CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 30347878886--579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 2 FLEYRMDRCVF--TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 2 f~~y~~~~C~F--n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) ...+.+.-|.- +++ .++....+-||.+.++.||.+...+++.++.++...+.||++.. .+..|.-.+.-| T Consensus 93 HtlQ~~~GCE~~~dg~---~~~g~~~~~ydG~dfl~fd~~~~~w~~~~~~a~~~k~~w~~~~~-~~~~k~yl~~~C 164 (181) T d1kjva2 93 HTIQEMYGCDVGSDGS---LLRGYEQFAYDGRDYIALNEDLKTWTAADFAARISRNKLERDGF-ADLHRAYLEGEC 164 (181) T ss_dssp CEEEEEEEEEECTTSC---EEEEEEEEEETTEEEEEECTTSSCEEECSHHHHHHHHHHHHTTH-HHHHHHHHHTHH T ss_pred EEEEEEEEEEECCCCC---EEEEEEEECCCCCEEEEEECCCCEEECCCHHHHHHHHHHHHHHH-HHHHHHHHHCCC T ss_conf 4899987666647997---73004651337820025536744487188899999998522678-999876550322 No 100 >d1neza2 d.19.1.1 (A:1-181) Class I MHC, alpha-1 and alpha-2 domains {Mouse (Mus musculus), tla(c), H-2 class} Probab=95.05 E-value=0.24 Score=30.47 Aligned_columns=68 Identities=18% Q ss_pred EEEEEEEEE--CCCCCCCEEEEEEEEECCEEEEEEECCCCEEEECCCCCCCCHHHCCCCHHHHHHHHHHHCCCC Q ss_conf 347878886--579962058998887576999998077774870173014032450688669776754203400 Q Psfainz_l4 4 EYRMDRCVF--TSPDLKDIEYYSSYNYNKIKYVEFSSSLGKFVGYNEVGVKQAEAWNKDQGQLAVWRAQKETYC 75 (84) Q Consensus 4 ~y~~~~C~F--n~tel~dv~~i~ry~yNk~e~~rFdSdvGkfvg~TelG~~~Ae~wN~~~~~Le~~Ra~vdt~C 75 (84) .+.+.-|.- +++ -.+-...+-||.+.|+.||.+...++|.++-+....+.|+ +....+..|+-.+.-| T Consensus 95 lQ~~~GCe~~~dg~---~~~g~~q~ayDG~d~l~ld~~~~tW~a~~~~A~~~k~kWe-~~~~~~~~k~yL~~~C 164 (181) T d1neza2 95 IQVMYGCEVEFFGS---LFRAYEQHGYDGQDYIALNEDLKTWTAADMAAEITRSKWE-QAGYTELRRTYLEGPC 164 (181) T ss_dssp EEEEEEEEEETTTT---EEEEEEEEEETTEEEEEECTTSSCEEESSHHHHHHHHHHH-HHTHHHHHHHHHHTHH T ss_pred EEEEEEEEECCCCC---EECCCEEECCCCHHHHEECCCCCEEECCCHHHHHHHHHHH-HHHHHHHHHHHHCCCC T ss_conf 88766554406774---2056043031880231012677668507789999998740-1778999864440533 Done!